Document:

Bonds.com 8-K

Exhibit 10.2

 

THE OFFER AND
SALE OF THIS COMMON Stock PURCHASE WARRANT AND THE SHARES OF COMMON STOCK THAT MAY BE PURCHASED HEREUNDER HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE SECURITIES LAWS OF ANY STATE.  THIS COMMON Stock PURCHASE
WARRANT AND THE SHARES OF COMMON STOCK THAT MAY BE PURCHASED HEREUNDER MAY NOT BE SOLD OR OFFERED FOR SALE IN THE ABSENCE OF AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND REGISTRATION OR QUALIFICATION UNDER APPLICABLE
STATE SECURITIES LAWS OR AN EXEMPTION THEREFROM.

BONDS.COM GROUP,
INC.

COMMON STOCK PURCHASE
WARRANT

Date of Issuance: February 28, 2013

THIS IS TO CERTIFY that Trimarc Capital Fund, L.P.,
a Delaware limited partnership, and its transferees, successors and assigns (the “Holder”), for good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, is entitled to purchase from BONDS.COM GROUP, INC.,
a Delaware corporation (the “Company”), at the price of $0.07 per share, as such price may be adjusted as provided
herein (the “Exercise Price”), at any time on or after the date hereof (the “Commencement Date”)
and expiring on the date that is five (5) years after the Commencement Date (the “Expiration Date”),
Twenty Eight Million Five Hundred Seventy One Thousand Four Hundred Twenty Nine (28,571,429) (the “Aggregate Number”)
shares of the fully paid and nonassessable Common Stock, par value $0.0001 per share, of the Company (the “Common Stock”)
(as such number may be adjusted as provided herein).

Capitalized terms used herein shall have
the meanings ascribed to such terms in Section 11 hereof unless otherwise defined herein.

SECTION
1.               
The Warrant; Transfer and Exchange.

(a)               
The Warrant.  This Common Stock Purchase Warrant (this “Warrant”) is issued under and
pursuant to the Unit Purchase Agreement, dated as of the date hereof, by and between the Company, the Holder and any other parties
set forth on Schedule 1 thereto (the “Unit Purchase Agreement”).  This Warrant and the
rights and privileges of the Holder hereunder may be exercised by the Holder in whole or in part as provided herein, shall survive
any termination of the Unit Purchase Agreement and, as more fully set forth in Sections 1(b) and 8 hereof, may be transferred
(subject to applicable securities laws and regulations) by the Holder to any other Person or Persons at any time or from time
to time, in whole or in part, regardless of whether the Holder retains any or all rights under the Unit Purchase Agreement.

(b)              
Transfer and Exchanges.  The Company shall initially record this Warrant on a register to be maintained
by the Company with its other stock books and, subject to Section 8 hereof, from time to time thereafter shall reflect the transfer
of this Warrant on such register when surrendered for transfer in accordance with the terms hereof and properly endorsed, accompanied
by appropriate instructions, and further accompanied by payment in cash or by check, bank draft or money order payable to the
order of the Company, in United States currency, of an amount equal to any stamp or other tax or governmental charge or fee required
to be paid in connection with the transfer thereof.  Upon any such transfer, a new warrant or warrants shall be issued
to the transferee and the Holder (in the event this Warrant is only partially transferred) and the surrendered warrant shall be
canceled.  Each such transferee shall succeed to all of the rights of the Holder with respect to the Warrant being so
transferred; provided, however, that, in the event this Warrant is partially transferred, the Holder and such transferee
shall hold rights in respect of this Warrant in proportion to their respective interests in this Warrant.  This Warrant
may be exchanged at the option of the Holder, when surrendered at the Principal Office, for another warrant or other warrants
of like tenor and representing in the aggregate the right to purchase a like number of shares of Common Stock.

    	1

    	 

    

SECTION
2.               
Exercise.

(a)               
Right to Exercise.  At any time after the Commencement Date and on or before the Expiration Date, the Holder,
in accordance with the terms hereof, may exercise this Warrant, in whole at any time or in part from time to time, by delivering
this Warrant to the Company during normal business hours on any Business Day at the Principal Office, together with the Election
to Purchase, in the form attached hereto as Exhibit A and made a part hereof (the “Election to Purchase”),
duly executed, and payment of the Exercise Price per share for the number of shares to be purchased (the “Exercise Amount”),
as specified in the Election to Purchase.  If the Expiration Date is not a Business Day, then this Warrant may be exercised
on the next succeeding Business Day.

(b)              
Payment of Exercise Price.  Payment of the Exercise Price shall be made to the Company by either of the
following means (or any combination of such means): (i) in cash or other immediately available funds, payable by certified wire
transfer to an account designated by the Company or (ii) as provided in Section 2(c).  The amount of the Exercise Price
to be paid shall equal the product of (A) the Exercise Amount multiplied by (B) the Exercise Price per share.

(c)               
Cashless Exercise.  The Holder shall have the right to pay all or a portion of the Exercise Price by making
a “Cashless Exercise” pursuant to this Section 2(c), in which case the portion of the Exercise Price to be so paid
shall be paid by reducing the number of shares of Common Stock otherwise issuable pursuant to the Election to Purchase (the “Exercise
Shares”) by an amount (the “Cashless Exercise Shares”) equal to (i) the Exercise Price multiplied
by the Exercise Shares and divided by (ii) the Fair Market Value Per Share of the Common Stock determined as of the Business Day
immediately preceding the date of such exercise of this Warrant.  The number of shares of Common Stock to be issued
to the Holder as a result of a Cashless Exercise will therefore be equal to the Exercise Shares minus the Cashless Exercise Shares. 

(d)              
Issuance of Shares of Common Stock.  Upon receipt by the Company of this Warrant at the Principal Office
in proper form for exercise, and accompanied by payment of the Exercise Price as aforesaid, the Company shall immediately cause
the shares of Common Stock to be registered in the name of the Holder in the Register of Stockholders of the Company and the Holder
shall then be deemed to be the holder of record of the shares of Common Stock issuable upon such exercise, notwithstanding that
certificates representing such shares of Common Stock may not then be actually delivered.  Upon such surrender of this
Warrant and payment of the Exercise Price as aforesaid, the Company shall issue and cause to be delivered with all reasonable
dispatch to, or upon the written order of, the Holder (and in such name or names as the Holder may designate) a certificate or
certificates for a number of shares of Common Stock equal to the Exercise Amount, subject to any reduction as provided in Section
2(c) for a Cashless Exercise.

    	2

    	 

    

(e)               
Fractional Shares.  The Company shall not be required to deliver fractions of shares of Common Stock upon
exercise of this Warrant.  If any fraction of a share of Common Stock would be deliverable upon an exercise of this Warrant,
the Company may, in lieu of delivering such fraction of a share of Common Stock, make a cash payment to the Holder in an amount
equal to the same fraction of the Fair Market Value Per Share of the Common Stock determined as of the Business Day immediately
preceding the date of exercise of this Warrant.

(f)               
Partial Exercise.  In the event of a partial exercise of this Warrant, the Company shall issue to the Holder
a Warrant in like form for the unexercised portion thereof.

SECTION
3.               
Payment of Taxes.

The Company shall pay all stamp taxes
attributable to the issuance of shares or other securities issuable upon the exercise of this Warrant or issuable pursuant to
Section 6 hereof.

SECTION
4.               
Replacement Warrant.

In case this Warrant is mutilated, lost,
stolen or destroyed, the Company shall issue and deliver in exchange and substitution for and upon cancellation of the mutilated
Warrant, or in lieu of and in substitution for the Warrant lost, stolen or destroyed, a new Warrant of like tenor and representing
an equivalent right or interest, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or
destruction of such Warrant and upon receipt of indemnity reasonably satisfactory to the Company (provided, that if the Holder
is a financial institution or other institutional investor, its personal undertaking to provide an indemnity is hereby deemed to
be reasonably satisfactory to the Company).

SECTION
5.               
Reservation of Capital Stock and Other Covenants.

(a)               
Reservation of Authorized Capital Stock.  The Company shall at all times ensure that it has sufficient
authorized and unissued capital, free of preemptive rights, to enable the Company at any time to fulfill all of its obligations
hereunder upon the exercise of this Warrant.

(b)              
Affirmative Actions to Permit Exercise and Realization of Benefits.  If any shares of Common Stock to
be issued upon the exercise of this Warrant, or any shares or other securities to be issued pursuant to Section 6 hereof, require
registration with or approval of any Governmental Authority under any federal or state law (other than securities laws) before
such shares or other securities may be validly delivered upon exercise of this Warrant or other securities that may be purchased
hereunder, then the Company covenants that it will, at its sole expense, and as promptly as practicable, secure such registration
or approval, as the case may be.

    	3

    	 

    

(c)               
Validly Issued Shares.  The Company covenants that all shares of Common Stock delivered upon exercise of
this Warrant, assuming full payment of the Exercise Price, shall, upon delivery by the Company, be duly authorized and validly
issued, fully paid and nonassessable, free from all stamp taxes, liens and charges with respect to the issue or delivery thereof
and otherwise free of all other security interests, encumbrances and claims of any nature whatsoever other than such security interests,
encumbrances and claims granted by the Holder.

SECTION
6.               
Adjustments. 

Under certain conditions, the Aggregate
Number is subject to adjustment as set forth in this Section 6.  

(a)               
Adjustments to Aggregate Number.  The Aggregate Number, after taking into consideration any prior adjustments
pursuant to this Section 6, shall be subject to adjustment from time to time as follows and, thereafter, as adjusted, shall be
deemed to be the Aggregate Number hereunder.

(i)                
Stock Dividends; Subdivisions, Combinations and Reclassifications.  In case at any time or from time to
time the Company shall:

(A)             
issue to the holders of the Common Stock a dividend payable in, or other distribution of,
Common Stock (a “Stock Dividend”),

(B)             
subdivide its outstanding shares of Common Stock into a larger number of shares of Common
Stock, including, without limitation, by means of a stock split (a “Stock Subdivision”), 

(C)             
combine its outstanding shares of Common Stock into a smaller number of shares of Common Stock
(a “Stock Combination”), or 

(D)             
issue any shares of its capital stock in a reclassification of the Common Stock (a “Stock
Reclassification”),

then the number of shares of Common Stock purchasable upon
exercise of this Warrant, if any, immediately prior thereto shall be adjusted so that the Holder shall be entitled to receive the
kind and number of shares of Common Stock or other securities of the Company which it would have owned or have been entitled to
receive had this Warrant been exercised in advance thereof.

(ii)              
Miscellaneous.  The following provisions shall be applicable to the making
of adjustments of the Aggregate Number provided above in this Section 6(a)

(A)             The
adjustments required by the preceding paragraphs of this Section 6(a) shall be made whenever and as often as any
specified event requiring an adjustment shall occur, except that no adjustment of the Aggregate Number that would
otherwise be required shall be made (except in the case of a Stock Subdivision, Stock Combination or Stock Reclassification
as provided for in Section 6(a)(i) hereof) unless and until such adjustment either by itself or with other adjustments not
previously made adds or subtracts at least one one-hundredth of one share to or from the Aggregate Number immediately prior
to the making of such adjustment.  Any adjustment representing a change of less than such minimum amount (except as
aforesaid) shall be carried forward and made as soon as such adjustment, together with other adjustments required by this
Section 6(a) and not previously made, would result in a minimum adjustment.  For the purpose of any adjustment, any
specified event shall be deemed to have occurred at the close of business on the date of its occurrence. 

    	4

    	 

    
 

(B)             
In computing adjustments under this Section 6(a), fractional interests in Common Stock shall be taken into account
to the nearest one-thousandth of a share.

(C)             
If the Company shall take a record of the holders of the Common Stock for the purpose of entitling them to receive
a dividend or distribution or subscription or purchase rights and shall, thereafter and before the distribution to shareholders
thereof, legally abandon its plan to pay or deliver such dividend, distribution, subscription or purchase rights, then no adjustment
shall be required by reason of the taking of such record and any such adjustment previously made in respect thereof shall be rescinded
and annulled.

(b)              
Adjustment to Exercise Price.

(i)                
Upon any adjustment to the Aggregate Number or of the kind and number of Warrant Shares or other securities of the Company
which are purchasable hereunder pursuant to Section 6(a)(i), the Holder shall thereafter be entitled to purchase such Aggregate
Number of shares of Common Stock or other securities resulting from such adjustment at an Exercise Price per share of Common Stock
or other security obtained by multiplying the Exercise Price in effect immediately prior to such adjustment by the Aggregate Number
prior to such adjustment and dividing by the Aggregate Number immediately following such adjustment. An adjustment made pursuant
to this paragraph shall become effective immediately after the effective date of such event retroactive to the record date, if
any, for such event. 

(ii)              
In case at any time or from time to time the Company shall pay a dividend or make a distribution in cash, securities or
other assets to the holders of Common Stock, other than (x) as described in Sections 6(a)(i)(A) and 6(a)(i)(D) above or (y) regular
quarterly or other periodic dividends (any such non-excluded event being referred to as an “Extraordinary Dividend”),
then the Exercise Price shall be decreased by the amount of cash and/or the fair market value (as determined by the Board of Directors
of the Company, in good faith) of any securities or other assets paid on each share of Common Stock in respect of such Extraordinary
Dividend. An adjustment made pursuant to this Section 6(b)(ii) shall become effective immediately after the effective date of
such event retroactive to the record date, if any, for such event.

(iii)            
Except for Exempted Securities and (y) pursuant to options, warrants and conversion rights in existence on the date of issuance
hereof, if and whenever on or after the date of issuance hereof until December 8, 2013, the Company shall issue or sell or shall
in accordance with subparagraphs (1) to (9) of this Section 6(b)(iii), inclusive, be deemed to have issued or sold, any shares
of its Common Stock for a consideration per share less than the Exercise Price in effect immediately prior to the time of such
issue or sale, then forthwith upon such issue or sale (the “Triggering Transaction”), the Exercise Price shall,
subject to subparagraphs (1) to (9) of this Section 6(b)(iii), inclusive, be reduced to the Exercise Price (calculated to the nearest
one-hundredth of a cent) determined by dividing:

    	5

    	 

    

(A)            
an amount equal to the sum of (x) the product derived by multiplying the Number of Common Shares Deemed Outstanding
immediately prior to such Triggering Transaction by the Exercise Price then in effect, plus (y) the consideration, if any, received
by the Company upon consummation of such Triggering Transaction, by

(B)             
an amount equal to the sum of (x) the Number of Common Shares Deemed Outstanding immediately prior to such Triggering
Transaction plus (y) the number of shares of Common Stock issued (or deemed to be issued in accordance with subparagraphs (1) to
(9) of this Section 6(b)(iii), inclusive) in connection with the Triggering Transaction.

For purposes of this Section 6(b)(iii),
the term “Number of Common Shares Deemed Outstanding” at any given time shall mean the sum of (x) the number
of shares of the Company’s Common Stock outstanding at such time, and (y) the number of shares of the Company’s Common
Stock deemed to be outstanding under subparagraphs (1) to (9) of this Section 6(b)(iii), inclusive, at such time.

For purposes of determining the adjusted Exercise
Price under this Section 6(b)(iii), the following subparagraphs (1) to (9), inclusive, shall be applicable:

(1)              
In case the Company at any time shall in any manner grant (whether directly or by assumption in a merger or otherwise) any
rights to subscribe for or to purchase, or any options for the purchase of, Common Stock (“Options”) or any
Convertible Securities, whether or not such Options or the right to convert or exchange any such Convertible Securities are immediately
exercisable and the price per share for which the Common Stock is issuable upon exercise, conversion or exchange (determined by
dividing (x) the total amount, if any, received or receivable by the Company as consideration for the granting of such Options,
plus the minimum aggregate amount of additional consideration payable to the Company upon the exercise of all such Options, plus,
in the case of such Options which relate to Convertible Securities, the minimum aggregate amount of additional consideration, if
any, payable upon the issue or sale of such Convertible Securities and upon the conversion or exchange thereof, by (y) the total
maximum number of shares of Common Stock issuable upon the exercise of such Options or the conversion or exchange of such Convertible
Securities) shall be less than the Exercise Price in effect immediately prior to the time of the granting of such Option, then
the total maximum amount of Common Stock issuable upon the exercise of such Options, or, in the case of Options for Convertible
Securities, upon the conversion or exchange of such Convertible Securities, shall (as of the date of granting of such Options)
be deemed to be outstanding and to have been issued and sold by the Company for such price per share. No adjustment of the Exercise
Price shall be made upon the actual issue of such shares of Common Stock or such Convertible Securities upon the exercise of such
Options, except as otherwise provided in subparagraph (3) below.

    	6

    	 

    
(2)              
In case the Company at any time shall in any manner issue (whether directly or by assumption in a merger or otherwise)
or sell any Convertible Securities, whether or not the rights to exchange or convert thereunder are immediately exercisable, and
the price per share for which Common Stock is issuable upon such conversion or exchange (determined by dividing (x) the total
amount received or receivable by the Company as consideration for the issue or sale of such Convertible Securities, plus the minimum
aggregate amount of additional consideration, if any, payable to the Company upon the conversion or exchange thereof, by (y) the
total maximum number of shares of Common Stock issuable upon the conversion or exchange of all such Convertible Securities) shall
be less than the Exercise Price in effect immediately prior to the time of such issue or sale, then the total maximum number of
shares of Common Stock issuable upon conversion or exchange of all such Convertible Securities shall (as of the date of the issue
or sale of such Convertible Securities) be deemed to be outstanding and to have been issued and sold by the Company for such price
per share. No adjustment of the Exercise Price shall be made upon the actual issue of such Common Stock upon exercise of the rights
to exchange or convert under such Convertible Securities, except as otherwise provided in subparagraph (3) below.

(3)              
If the purchase price provided for in any Options referred to in subparagraph (1), the additional consideration, if any,
payable upon the conversion or exchange of any Convertible Securities referred to in subparagraphs (1) or (2), or the rate at which
or number of shares of Common Stock for which any Convertible Securities referred to in subparagraph (1) or (2) are convertible
into or exchangeable for Common Stock shall change at any time (other than under or by reason of provisions designed to protect
against dilution of the type set forth in Section 6(a)(i)(B), Section 6(a)(i)(c) or 6(b)(iii)), the Exercise Price in effect at
the time of such change shall forthwith be readjusted to the Exercise Price which would have been in effect at such time had such
Options or Convertible Securities still outstanding provided for such changed purchase price, additional consideration or conversion
rate, as the case may be, at the time initially granted, issued or sold. If the purchase price provided for in any Option referred
to in subparagraph (1) or the rate at which or number of shares of Common Stock for which any Convertible Securities referred to
in subparagraphs (1) or (2) are convertible into or exchangeable for Common Stock, shall be reduced at any time under or by reason
of provisions with respect thereto designed to protect against dilution, then in case of the delivery of Common Stock upon the
exercise of any such Option or upon conversion or exchange of any such Convertible Security, the Exercise Price then in effect
hereunder shall forthwith be adjusted to such respective amount as would have been obtained had such Option or Convertible Security
never been issued as to such Common Stock and had adjustments been made upon the issuance of the shares of Common Stock delivered
as aforesaid, but only if as a result of such adjustment the Exercise Price then in effect hereunder is hereby reduced.

(4)              
On the expiration of any Option or the termination of any right to convert or exchange any Convertible Securities, the Exercise
Price then in effect hereunder shall forthwith be increased to the Exercise Price which would have been in effect at the time of
such expiration or termination had such Option or Convertible Securities, to the extent outstanding immediately prior to such expiration
or termination, never been issued.

(5)              
In case any Options shall be issued in connection with the issue or sale of other securities of the Company, together comprising
one integral transaction in which no specific consideration is allocated to such Options by the parties thereto, such Options shall
be deemed to have been issued without consideration.

    	7

    	 

    
(6)              
In case any shares of Common Stock, Options or Convertible Securities shall be issued or sold or deemed to have been issued
or sold for cash, the consideration received therefor shall be deemed to be the amount received by the Company therefor. In case
any shares of Common Stock, Options or Convertible Securities shall be issued or sold for a consideration other than cash, the
amount of the consideration other than cash received by the Company shall be the fair value of such consideration as determined
in good faith by the Board of Directors. In case any shares of Common Stock, Options or Convertible Securities shall be issued
in connection with any merger in which the Company is the surviving corporation, the amount of consideration therefor shall be
deemed to be the fair value of such portion of the net assets and business of the non-surviving corporation as shall be attributed
by the Board of Directors in good faith to such Common Stock, Options or Convertible Securities, as the case may be. If the number
of shares of Common Stock issuable upon the exercise, conversion and/or exchange of any Option or Convertible Securities, or the
consideration payable to the Company upon such exercise, conversion and/or exchange, cannot be calculated at all at the time such
Option or Convertible Securities are issued or amended, any adjustment to the Exercise Price that would result under the terms
of this Section 6(b)(iii) at the time of such issuance or amendment shall instead be effected at the time such number of shares
and/or amount of consideration is first calculable (even if subject to subsequent adjustments), assuming for purposes of calculating
such adjustment to the Exercise Price that such issuance or amendment took place at the time such calculation can first be made.

(7)              
The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the
account of the Company, and the disposition of any shares so owned or held shall be considered an issue or sale of Common Stock
for the purpose of this Section 6(b)(iii).

(8)              
In case the Company shall declare a dividend or make any other distribution upon the stock of the Company payable in Options
or Convertible Securities, then in such case any Options or Convertible Securities, as the case may be, issuable in payment of
such dividend or distribution shall be deemed to have been issued or sold without consideration.

(9)              
For purposes of this Section 6(b)(iii), in case the Company shall take a record of the holders of its Common Stock for the
purpose of entitling them (x) to receive a dividend or other distribution payable in Common Stock, Options or in Convertible Securities,
or (y) to subscribe for or purchase Common Stock, Options or Convertible Securities, then such record date shall be deemed to be
the date of the issue or sale of the shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend
or the making of such other distribution or the date of the granting of such right or subscription or purchase, as the case may
be.

    	8

    	 

    
 

(c)               
Changes in Common Stock.  In case at any time the Company shall initiate any transaction or be a party
to any transaction (including, without limitation, a merger, consolidation, share exchange, sale, lease or other disposition of
all or substantially all of the Company’s assets, liquidation, recapitalization or reclassification of the Common Stock)
in connection with which the previous outstanding Common Stock shall be changed into or exchanged for different securities of
the Company or Capital Stock or other securities of another corporation or interests in a non-corporate entity or other property
(including cash) or any combination of the foregoing (each such transaction being herein called a “Transaction”),
then, as a condition of the consummation of the Transaction, lawful, enforceable and adequate provision shall be made so that
the Holder shall be entitled to elect, by written notice to the Company, to receive (i) in exchange for the surrender of this
Warrant to the Company and the same Exercise Price (rather than the exercise thereof), the securities or other property (including
cash) to which such Holder would have been entitled upon consummation of the Transaction if such Holder had exercised this Warrant
and (if applicable) converted the shares of Common Stock issuable hereunder immediately prior thereto, (ii) a new warrant in form
and substance similar to, and in exchange for, this Warrant to purchase all or a portion of such securities or other property
to which such Holder would have been entitled upon consummation of the Transaction if such Holder had exercised this Warrant and
(if applicable) converted the shares of Common Stock issuable hereunder immediately prior thereto, for the same Exercise Price,
or (iii) upon exercise of this Warrant at any time on or after the consummation of the Transaction but prior to the Expiration
Date, in lieu of the Warrant Shares issuable upon such exercise prior to such consummation, the securities or other property (including
cash) to which such Holder would have been entitled upon consummation of the Transaction if such Holder had exercised this Warrant
and (if applicable) converted the shares of Common Stock issuable hereunder immediately prior thereto (subject to adjustments
from and after the consummation date as nearly equivalent as possible to the adjustments provided for in this Section 6 ).  The
Company will not effect any Transaction unless prior to the consummation thereof each corporation or other entity (other than
the Company) which may be required to deliver any new warrant, securities or other property as provided herein shall assume by
written instrument the obligation to deliver to such Holder such new warrant, securities or other property as in accordance with
the foregoing provisions such Holder may be entitled to receive.  The foregoing provisions of this Section 6(c) shall
similarly apply to successive Transactions.

(d)              
Other Action Affecting Capital Stock. 

(i)                
Other Action.  In case at any time or from time to time the Company shall take any action of the type
contemplated in Section 6(a) or (c) hereof but not expressly provided for by such provisions, then, unless in the opinion of the
Board of Directors such action will not have a material adverse effect upon the rights of the Holder (taking into consideration,
if necessary, any prior actions which the Board of Directors deemed not to materially adversely affect the rights of the Holder),
the Aggregate Number shall be adjusted in such manner and at such time as the Board of Directors may in good faith determine to
be equitable in the circumstances.

    	9

    	 

    

(e)               
Notices.

(i)                
Notice of Proposed Actions.  In case the Company shall propose (A) to pay any dividend payable in stock
of any class to the holders of the Common Stock or to make any other distribution to the holders of the Common Stock, (B) to offer
to the holders of the Common Stock rights to subscribe for or to purchase any Convertible Securities or additional shares of Common
Stock or shares of stock of any class or any other securities, warrants, rights or options (other than the exercise of pre-emptive
rights by a holder), (C) to effect any reclassification of the Common Stock, (D) to effect any recapitalization, stock subdivision,
stock combination or other capital reorganization, (E) to effect any consolidation or merger, share exchange, or sale, lease or
other disposition of all or substantially all of its property, assets or business, (F) to effect the liquidation, dissolution
or winding up of the Company, (G) to effect a Change of Control (provided that notice of a Change of Control shall only be provided
upon the Company entering into a definitive agreement with respect to such Change of Control and such information not being material
non public information) or Transaction or (H) to effect any other action which would require an adjustment under this Section
6, then, in each such case, the Company shall give to the Holder written notice of such proposed action, which shall specify
the date on which a record is to be taken for the purposes of such stock dividend, stock subdivision, stock combination, distribution
or rights, or the approximate date on which such reclassification, recapitalization, reorganization, consolidation, merger, share
exchange, sale, lease, transfer, disposition, liquidation, dissolution, winding up or other transaction is expected to take place
and the expected date of participation therein by the holders of Common Stock (as applicable), if any such date is to be fixed,
or the date on which the transfer of Common Stock (as applicable) is expected to occur, and shall also set forth such facts with
respect thereto as shall be reasonably necessary to indicate the effect of such action on the Common Stock (as applicable) and
on the Aggregate Number after giving effect to any adjustment which will be required as a result of such action.  Such
notice shall be so given in the case of any action covered by clause (A) or (B) above at least ten (10) Business Days prior to
the record date for determining holders of the Common Stock (as applicable) for purposes of such action and, in the case of any
other such action, at least ten (10) Business Days prior to the earlier of the date of the taking of such proposed action or the
date of participation therein by the holders of Common Stock (as applicable).

(ii)              
Adjustment Notice.  Whenever the Aggregate Number is to be adjusted pursuant to this Section 6, unless
otherwise agreed by the Holder, the Company shall promptly (and in any event within ten (10) Business Days after the event requiring
the adjustment) prepare a certificate signed by the Chief Financial Officer of the Company, setting forth, in reasonable detail,
the event requiring the adjustment and the method by which such adjustment is to be calculated.  The certificate shall
set forth, if applicable, a description of the basis on which the Board of Directors in good faith determined, as applicable,
the Fair Market Value Per Share or the fair market value of any evidences of indebtedness, shares of stock, other securities,
warrants, other subscription or purchase rights, or other property or the equitable nature of any adjustment under Section 6(c)
or (d) hereof, the new Aggregate Number and, if applicable, any new securities or property to which the Holder is entitled.  The
Company shall promptly cause a copy of such certificate to be delivered to the Holder.  Any other determination of fair
market value shall first be determined in good faith by the Board of Directors and be based upon an arm’s length sale of
such indebtedness, shares of stock, other securities, warrants, other subscription or purchase rights or other property, such
sale being between a willing buyer and a willing seller.  In the case of any such determination of fair market value,
the Holder may object to the determination in such certificate by giving written notice within ten (10) Business Days of the receipt
of such certificate and, if the Holder and the Company cannot agree to the fair market value within ten (10) Business Days of
the date of the Holder’s objection, the fair market value shall be determined by a national or regional investment bank
or a national accounting firm mutually selected by the Holder and the Company, the fees and expenses of which shall be paid 50%
by the Company and 50% by the Holders that did not agree with the valuation determined by the Company unless such determination
results in a fair market value more than 110% of the fair market value determined by the Company, in which case such fees and
expenses shall be paid by the Company.  The Company shall keep at the Principal Office copies of all such certificates
and cause the same to be available for inspection at said office during normal business hours by the Holder or any prospective
purchaser of this Warrant (in whole or in part) if so designated by the Holder.

    	10

    	 

    

SECTION
7.               
No Impairment.

The Company will not, by amendment
of its organizational documents or through any reorganization, recapitalization, transfer of assets, consolidation, merger,
share exchange, dissolution or any other voluntary and deliberate action, avoid or seek to avoid the observance or
performance of any of the terms of this Warrant, including, without limitation, the adjustments required under Section 6
hereof, and will at all times in good faith assist in the carrying out of all such terms and in taking of all such action as
may be necessary or appropriate to protect the rights of the Holder against other impairment.  Without limiting the
generality of the foregoing and notwithstanding any other provision of this Warrant to the contrary (including by way of
implication), the Company (a) will not increase the par value of any shares of Common Stock receivable on the exercise of
this Warrant above the amount payable therefor on such exercise and (b) will take all such action as may be necessary or
appropriate so that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock on the
exercise of this Warrant.

SECTION
8.               
Transfers of this Warrant.

(a)                Generally.  Subject
to the restrictions set forth in this Sections 1 and 8 of this Warrant, the Holder may at any time and from time to time
freely transfer this Warrant and the Warrant Shares in whole or in part.

(b)              
Compliance with Securities Laws.  The Holder agrees that this Warrant and the Warrant Shares may not be
sold or otherwise disposed of except pursuant to an effective registration statement under the Securities Act and applicable state
securities laws or pursuant to an applicable exemption from the registration requirements of the Securities Act and such state
securities laws.  In the event that the Holder transfers this Warrant or the Warrant Shares pursuant to an applicable
exemption from registration, the Company may request, at the Holder’s expense, an opinion of counsel that the proposed transfer
does not violate the Securities Act and applicable state securities laws. 

(c)               
Restrictive Securities Legend.  For so long as the Warrant Shares have not been registered under the Securities
Act pursuant to the Registration Rights Agreement, the certificate representing the Warrant Shares shall bear the restrictive legend
set forth below:

“The offer and sale of the shares represented by
this certificate have not been registered under the Securities Act of 1933, as amended, or the securities laws of any State and
may not be sold or otherwise disposed of except pursuant to an effective registration statement under such Act and applicable State
securities laws or pursuant to an applicable exemption from the registration requirements of such Act and such laws.”

    	11

    	 

    

SECTION
9.               
Events of Non-Compliance and Remedies.

(a)               
Events of Non-Compliance.  If the Company fails to keep and fully and promptly perform and observe in
any material respect any of the terms, covenants or representations contained or referenced herein within thirty (30) days from
the earlier to occur of (i) written notice from the Holder specifying what failure has occurred, or requesting that a specified
failure be remedied or (ii) an executive officer of the Company becoming aware of such failure (an “Event of Non-Compliance”),
the Holder shall be entitled to the remedies set forth in subsection (b) hereof.

(b)              
Remedies.  On the occurrence of an Event of Non-Compliance, in addition to any remedies the Holder may
have under applicable law the Holder may bring any action for injunctive relief or specific performance of any term or covenant
contained herein, the Company hereby acknowledging that an action for money damages may not be adequate to protect the interests
of the Holder hereunder.

SECTION
10.           
Definitions.

As used herein, in addition to the terms
defined elsewhere herein, the following terms shall have the following meanings.  

“Aggregate Number”
has the meaning set forth in the Preamble.

“Board of Directors”
means the Board of Directors of the Company.

“Business Day” means
any day other than a Saturday, Sunday or other day on which commercial banks in the State of New York are authorized or required
by law or executive order to close.

“Capital Stock” means
(a) with respect to any Person that is a corporation, any and all shares, interests or equivalents in capital stock (whether voting
or nonvoting, and whether common or preferred) of such corporation, and (b) with respect to any Person that is not a corporation,
any and all partnership, membership, limited liability company or other equity interests of such Person that confer on a Person
the right to receive a share of the profits and losses of, or the distribution of assets of, the issuing Person; and in each case,
any and all warrants, rights or options to purchase any of the foregoing.

“Cashless Exercise Shares”
has the meaning set forth in Section 2(c).

    	12

    	 

    

“Change of Control”
means (A) a consolidation, merger, reorganization or other form of acquisition of or by the Company in which the Company’s
stockholders immediately prior to the transaction retain less than 50% of the voting power of, or economic interest in, the surviving
or resulting entity (or its parent), (B) a sale of more than a majority of the Company’s assets, (C) the acquisition by any
person or group of persons of more than 50% of the Company’s outstanding voting securities or (D) during any period of twenty-four
(24) consecutive months, Continuing Directors (as defined below) cease for any reason to constitute a majority of the directors
of the Board of Directors or the board of directors of the surviving or resulting entity (or its parent).

“Commencement Date”
has the meaning set forth in the Preamble. 

“Common Stock” means
the Company’s Common Stock, par value $0.0001 per share.

“Company” has the
meaning set forth in the Preamble.

“Continuing Director”
means, as of any determination date, any member of the Board of Directors or the board of directors of the surviving or resulting
entity (or its parent) who: (A) was a member of the Board of Directors as of February 2, 2011, (B) was a member of the Board of
Directors on the date that was twenty-four (24) months prior to such determination date, (C) was a Series E Designee, GFI Designee,
DBIC Designee, Oak Designee or Trimarc Designee (as such terms are defined in the Stockholders’ Agreement), (D) was
nominated with the approval of a majority of the Continuing Directors who were members of the Board of Directors at the time of
such nomination, or (E) was elected with the approval of holders of at least a majority of the Series E Preferred Stock and Series
E-2 Preferred Stock, voting together as a separate class.

“Convertible Securities”
means (i) evidences of indebtedness, shares of stock or other securities (including, without limitation, options and warrants)
that are directly or indirectly convertible, exercisable or exchangeable, with or without payment of additional consideration in
cash or property, for shares of Common Stock (as applicable), either immediately or upon the onset of a specified date or the happening
of a specified event or (ii) stock appreciation rights, phantom stock rights or other rights with equity features.

“Election to Purchase”
has the meaning set forth in Section 2(a).

“Event of Non-Compliance”
has the meaning set forth in Section 9(a).

“Exercise Amount”
has the meaning set forth in Section 2(a).

“Exercise Price” has
the meaning set forth in the Preamble.

“Exempted Securities”
has the meaning set forth in the Certificate of Designation of the Series E Convertible Preferred Stock, Series E-1 Convertible
Preferred Stock, and Series E-2 Convertible Preferred Stock of Bonds.com Group, Inc.

“Exercise Shares”
has the meaning set forth in Section 2(c).

“Expiration Date”
has the meaning set forth in the Preamble.

“Extraordinary Dividend”
has the meaning set forth in Section 6(b)(ii).

    	13

    	 

    

“Fair Market Value Per Share”
means, with respect to a share of Common Stock on any date: (a) if the shares are listed or admitted for trading on any national
securities exchange or included in The NASDAQ National Market or NASDAQ SmallCap Market, the last reported sales price as reported
on such exchange or market; (b) if the shares are not listed or admitted for trading on any national securities exchange or included
in The NASDAQ National Market or NASDAQ SmallCap Market, the average of the last reported closing bid and asked quotation for the
shares as reported on the National Association of Securities Dealers Automated Quotation System (“NASDAQ”) or
a similar service if NASDAQ is not reporting such information; and (c) if the shares are not listed or admitted for trading on
any national securities exchange or included in The NASDAQ National Market or NASDAQ SmallCap Market or quoted by NASDAQ or a similar
service, the average of the last reported bid and asked quotation for the shares as quoted by a market maker in the shares (or
if there is more than one market maker, the bid and asked quotation shall be obtained from two market makers and the average of
the lowest bid and highest asked quotation).  In the absence of any available public quotations for the Common Stock, the
Board of Directors shall determine in good faith the fair value of the Common Stock.

“Governmental Authority”
means the government of any nation, state, city, locality or other political subdivision of any thereof, any entity or person exercising
executive, legislative, judicial, arbitral, regulatory or administrative functions of or pertaining to government, regulation or
compliance.

“Holder” or “Holders”
means any holder of an interest in this Warrant or the outstanding Warrant Shares.

“Number of Common Shares Deemed
Outstanding” has the meaning set forth in Section 6(b)(iii).

“Options” has the
meaning set forth in Section 6(b)(iii)(1).

“Person” means any
individual, firm, corporation, partnership, limited liability company, joint venture, incorporated or unincorporated association,
joint stock company, Governmental Authority, or other entity of any kind, and shall include any successor (by merger or otherwise)
of such entity.

“Principal Office”
means the Company’s principal office as set forth in Section 16 hereof or such other principal office of the Company in the
United States of America the address of which first shall have been set forth in a notice to the Holder.

“Registration Rights Agreement”
means the Second Amended and Restated Registration Rights Agreement dated as of the date hereof among the Company, the Holder and
the other parties set forth on Schedule I thereto, as amended or supplemented from time to time.

“Securities Act” means
the Securities Act of 1933, as amended, or any similar federal statute, and the rules and regulations thereunder as the same shall
be in effect at the time.

“Stock Combination”
has the meaning set forth in Section 6(a)(i)(C).

“Stock Dividend” has
the meaning set forth in Section 6(a)(i)(A).

“Stock Reclassification”
has the meaning set forth in Section 6(a)(i)(D).

“Stock Subdivision”
has the meaning set forth in Section 6(a)(i)(B).

    	14

    	 

    

 “Stockholders’
Agreement” means the Amended and Restated Series E Stockholders’ Agreement dated as of the date hereof among the
Company, the Holder and the other parties set forth on Schedule A thereto, as amended or supplemented from time to time.

“Transaction” has
the meaning set forth in Section 6(c).

“Transaction Documents”
means this Warrant, the Unit Purchase Agreement, the Joinder to Registration Rights Agreement, the Stockholders’ Agreement
and any other agreements or documents delivered in connection herewith or therewith.

“Unit Purchase Agreement”
has the meaning set forth in Section 1(a).

“Warrant” has the
meaning set forth in Section 1(a).

“Warrant Shares” means
(a) the shares of Common Stock issued or issuable upon exercise of this Warrant in accordance with its terms and (b) all other
shares of the Company’s Capital Stock issued with respect to such shares by way of stock dividend, stock split or other reclassification,
pursuant to Section 6, or in connection with any merger, consolidation, recapitalization or other reorganization affecting the
Company’s Capital Stock.

SECTION
11.           
Survival of Provisions.

Notwithstanding the full exercise
by the Holder of its rights to purchase Common Stock hereunder, the provisions of Sections 9 through 21 of this Warrant shall
survive such exercise and the Expiration Date.

SECTION
12.           
Delays, Omissions and Waivers.

It is agreed that no delay or omission
to exercise any right, power or remedy accruing to the Holder upon any breach or default of the Company under this Warrant shall
impair any such right, power or remedy, nor shall it be construed to be a waiver of any such breach or default, or any acquiescence
therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be
deemed a waiver of any other breach or default theretofore or thereafter occurring.  It is further agreed that any waiver,
permit, consent or approval of any kind or character on the Holder’s part of any breach or default under this Warrant, or
any waiver on the Holder’s part of any provisions or conditions of this Warrant must be in writing and that all remedies,
either under this Warrant, or by law or otherwise afforded to the Holder, shall be cumulative and not alternative.

SECTION
13.           
Rights of Transferees.

Subject to Section 8, the rights granted
to the Holder hereunder of this Warrant shall pass to and inure to the benefit of all subsequent transferees of all or any portion
of this Warrant (provided that the Holder and any transferee shall hold such rights in proportion to their respective ownership
of this Warrant and Warrant Shares) until extinguished pursuant to the terms hereof.

    	15

    	 

    

		SECTION	14.           
Captions.

The titles and captions of the Sections
and other provisions of this Warrant are for convenience of reference only and are not to be considered in construing this Warrant.

SECTION
15.           
Notices.

All notices, demands and other communications
provided for or permitted hereunder shall be made in writing and shall be by registered or certified first-class mail, return receipt
requested, telecopy, overnight courier service or personal delivery:

	If to the Company:	
        Bonds.com Group, Inc.

        1500 Broadway, 31st Floor

        New York, New York 10036

        Attention:  Thomas Thees, Chief Executive Officer

        Fax No:  (212) 278-8934

	 	 
	With a copy to:	
        Hill Ward Henderson

        3700 Bank of America Plaza

        101 East Kennedy Boulevard

        Tampa, Florida 33602

        Attention:   Mark A. Danzi, Esq.

        Fax No.:  (813) 221-2900

	 	 
	If to the Holder:	
        Trimarc Capital Fund, L.P.

        400 Madison Avenue, Suite 9D

        New York, New York 10017

        Attention: Michael Trica

        Fax No.: (646) 607-9008

 

All such notices and communications shall be deemed to have
been duly given: when delivered by hand, if personally delivered; when delivered by courier, if delivered by commercial overnight
courier service; five Business Days after being deposited in the mail, postage prepaid, if mailed; and when receipt is acknowledged,
if telecopied.

SECTION
16.           
Successors and Assigns.

This Warrant shall be binding upon and
inure to the benefit of the parties hereto and their respective successors or heirs and personal representatives and permitted
assigns; provided, that the Company shall have no right to assign its rights, or to delegate its obligations, hereunder
without the prior written consent of the Holder except as otherwise expressly provided herein. 

    	16

    	 

    

SECTION
17.           
Governing Law, Jurisdiction, Jury Trial.

All questions concerning the construction,
validity, enforcement and interpretation of this Agreement shall be governed by the internal laws of the State of New York, without
giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that
the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and
consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address
for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted
by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

SECTION
18.           
Severability.

If any one or more of the provisions
contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable in any respect for
any reason, the validity, legality and enforceability of any such provision in every other respect and of the remaining provisions
hereof shall not be in any way impaired, unless the provisions held invalid, illegal or unenforceable shall substantially impair
the benefits of the remaining provisions hereof.  The parties hereto further agree to replace such invalid, illegal or
unenforceable provision of this Agreement with a valid, legal and enforceable provision that will achieve, to the extent possible,
the economic, business and other purposes of such invalid, illegal or unenforceable provision.

SECTION
19.           
Entire Agreement.

This Warrant, together with the other
Transaction Documents, contains the entire agreement among the parties with respect to the subject matter hereof and thereby supersedes
all prior and contemporaneous agreements or understandings with respect thereto.

SECTION
20.           
Headings.

The headings in this Warrant are for
convenience of reference only and shall not limit or otherwise affect the meaning hereof.

SECTION
21.           
No Strict Construction.

The Company and the Holder each acknowledge
that they have been represented by counsel in connection with this Warrant, the other Transaction Documents and the transactions
contemplated hereby and thereby.  The Company and the Holder have participated jointly in the negotiation and drafting
of this Warrant and the other Transaction Documents.  In the event an ambiguity or question of intent or interpretation
arises under any provision of this Warrant or any Transaction Document, this Warrant or such other Transaction Documents shall
be construed as if drafted jointly by the parties thereto, and no presumption or burden of proof shall arise favoring or disfavoring
any party by virtue of the authorship of any of the provisions of this Warrant or any other Transaction Document.

    	17

    	 

    

SECTION
22.           
Representations, Warranties and Covenants.

The Company hereby represents, warrants
and covenants to the Holder that, so long as the Holder holds this Warrant or any Warrant Shares, the Company will not, directly
or indirectly, create or otherwise cause or suffer to exist or become effective any restriction or encumbrance on the ability of
the Company to perform and comply with its obligations under this Warrant.

[REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK.  SIGNATURE PAGE FOLLOWS.]

 

 

     

     

    

IN WITNESS WHEREOF, the Company
has caused this Warrant to be issued and executed in its corporate name by its duly authorized officers and its corporate seal
to be affixed hereto as of the date below written. 

	DATED:  February 28, 2013	 	BONDS.COM GROUP, INC.
	 	 	 	 
	 	 	 	
	 	 	By:	
        /s/ Thomas Thees

	 	 	Name:	Thomas Thees
	 	 	Title:	Chief Executive Officer

 

     

     

    

EXHIBIT A

NOTICE OF EXERCISE; ELECTION TO PURCHASE

 

	To:	 	 
	 	 	 
	 	 	 

1.The undersigned, pursuant to the
provisions of the attached Warrant, hereby elects to exercise this Warrant with respect to ________ shares of Common Stock (the
“Exercise Amount”).  Capitalized terms used but not otherwise defined herein have the meanings ascribed
thereto in the attached Warrant.

 2.The undersigned herewith tenders
payment for such shares in the following manner (please check type, or types, of payment and indicate the portion of the Exercise
Price to be paid by each type of payment): 

_______  Exercise for Cash

_______  Cashless Exercise

3.Please issue a certificate or certificates
representing the shares issuable in respect hereof under the terms of the attached Warrant, as follows:

	 	 
	 	(Name of Record Holder/Transferee)

and deliver such certificate or certificates to the following
address:

	 	 
	 	(Address of Record Holder/Transferee)

4.The undersigned represents that the
aforesaid shares are being acquired for the account of the undersigned for investment and not with a view to, or for resale in
connection with, the distribution thereof and that the undersigned has no present intention of distributing or reselling such shares.

5.If the Exercise Amount is less than
all of the shares of Common Stock purchasable hereunder, please issue a new warrant representing the remaining balance of such
shares, as follows:

	 	 
	 	(Name of Record Holder/Transferee)

   and deliver such warrant to the following address:

	 	 
	 	(Address of Record Holder/Transferee)

 

	 	 
	 	(Signature)

 

	 	 	 
	(Date)	 	 

     

     

    

EXHIBIT B

ELECTION TO REDEEM

 

	To:	 	 
	 	 	 
	 	 	 

1.The undersigned, pursuant to the provisions
of the attached Warrant, hereby elects to require the Company to redeem this Warrant with respect to ________ shares of Common
Stock subject hereto (the “Redemption Amount”).  Capitalized terms used but not otherwise defined
herein have the meanings ascribed thereto in the attached Warrant.

2.Please pay the Redemption Price
according to the following instructions:

 

Account Number:

 

	 	 
	 	(Name of Record Holder/Transferee)Bonds.com 8-K 

 

Exhibit 10.3

 

 

AMENDED
AND RESTATED

SERIES
E StockHOLDERS’ AGREEMENT

 

This
AMENDED AND RESTATED SERIES E STOCKHOLDERS’ AGREEMENT (this “Agreement”) is entered into as of
February 28, 2013, by and among Bonds.com Group, Inc., a Delaware corporation (the “Company”), the stockholders
set forth on Schedule A hereto and each other stockholder who shall, subsequent to the date
hereof, join in and become a party to this Agreement (each a “Stockholder” and together with the stockholders
set forth on Schedule A, the “Stockholders”).

WHEREAS:

A.On
December 5, 2011, Daher Bonds Investment Company, a Cayman Islands company (“DBIC”), Mida Holdings, a Cayman
Islands company (“Mida”), GFINet Inc., a Delaware corporation (“GFI”), Oak Investment Partners
XII, Limited Partnership, a Delaware limited partnership (“Oak”) and certain other investors and the Company
entered into that certain Unit Purchase Agreement (the “2011 Purchase Agreement”), pursuant to which such buyers
purchased certain Units (“Units”) of the Company at an initial closing that occurred on December 5, 2011 and
a final closing that occurred on June 8, 2012, each Unit consisting of: (i) 100 shares (the “Shares”) of Series
E-2 Convertible Preferred Stock of the Company, par value $0.0001 per share (“Series E-2 Preferred Stock”),
and (ii) warrants exercisable for 1,428,571.429 shares of common stock of the Company (as adjusted thereafter for the reverse
stock split), par value $0.0001 per share (“Common Stock”) (the “Initial Series E-2 Transactions”).

B.On
December 5, 2011, the Company and certain of the Stockholders entered into that certain Exchange Agreement (the “Exchange
Agreement”), pursuant to which such Stockholders exchanged their shares of the Company’s Series D Convertible
Preferred Stock, par value $0.0001 per share (the “Series D Preferred Stock”), and Series D-1 Convertible Preferred
Stock, par value $0.0001 per share (the “Series D-1 Preferred Stock”), as applicable, for shares of the Company’s
Series E Convertible Preferred Stock, par value $0.0001 per share (the “Series E Preferred Stock”), and Series
E-1 Convertible Preferred Stock, par value $0.0001 per share (the “Series E-1 Preferred Stock”), respectively
(the “Exchange Transaction” and collectively with the Initial Series E-2 Transactions, the “Initial
Purchase and Exchange Transactions”).

C.Additionally,
on December 5, 2011 and in connection with the Initial Purchase and Exchange Transactions, the Company and certain of the Stockholders
set forth therein entered into the Series E Stockholders’ Agreement (the “Original Agreement”). The Original
Agreement superseded and replaced in its entirety that certain Series D Stockholders’ Agreement dated as of February 2,
2011, as amended by Amendment No. 1 to the Series D Stockholders’ Agreement dated as of June 23, 2011, between the Company
and the Stockholders named therein. The Original Agreement was amended by the Amendment No. 1 to Series E Stockholders’
Agreement dated May 16, 2012, between the Company and the Stockholders set forth therein (the “Amendment”).

D.Trimarc
Capital Fund, L.P., a Delaware limited partnership (“Trimarc”), and the Company are parties to that certain
Unit Purchase Agreement (the “February 2013 Purchase Agreement”), dated as of the date hereof, pursuant to
which Trimarc is purchasing Units (the “February 2013 Series E-2 Transaction” and collectively with the Initial
Purchase and Exchange Transactions, the “Transactions”).

    	1

    	 

    
 

E.This
Agreement amends and restates in its entirety the Original Agreement and the Amendment.

F.The
execution of this Agreement by the Company and the Stockholders is a condition precedent to the consummation of the February 2013
Series E-2 Transaction.

G.In
consideration of the benefits to be derived by the Company and the Stockholders from the consummation of the February 2013 Series
E-2 Transaction, the Company and the holders indentified on the counterpart signature pages hereto (the “Amending Holders”)
desire to enter into this Agreement. The Original Agreement (as amended by the Amendment) may be amended
by a written consent signed by the Company and the Required Holders (defined below). The Amending Holders constitute the Required
Holders for purposes of this Agreement.

NOW,
THEREFORE, in consideration of the foregoing and the mutual covenants and agreements contained herein, the parties hereto agree
as follows:

1.                 
Definitions. Capitalized terms used by not defined herein shall have the meanings set forth in the 2011 Purchase Agreement
or the February 2013 Purchase Agreement, as applicable. As used in this Agreement, the terms set forth below shall have the following
meanings:

(a)               
“Board” means the Company’s board of directors.

(b)              
“Business Day” means a day on which the New York Stock Exchange is open for business.

(c)               
“Change of Control” means (i) a consolidation, merger, reorganization or other form of acquisition of or by
the Company in which the Company’s stockholders immediately prior to the transaction retain less than 50% of the voting
power of, or economic interest in, the surviving or resulting entity (or its parent), (ii) a sale of more than a majority of the
Company’s assets, (iii) the acquisition by any person or group of persons of more than 50% of the Company’s outstanding
voting securities or (iv) during any period of twenty-four (24) consecutive months, Continuing Directors (as defined below) cease
for any reason to constitute a majority of the directors of the Board or the board of directors of the surviving or resulting
entity (or its parent). 

(d)              
“Common Securities” means shares of Common Stock or Warrants to purchase shares of Common Stock.

(e)               
“Common Stock” means the common stock, par value $0.0001 per share, of the Company.

(f)               
“Continuing Director” means, as of any determination date, any member of the Board or the board of directors
of the surviving or resulting entity (or its parent) who: (i) was a member of the Board as of February 2, 2011, (ii) was a member
of the Board on the date that was twenty-four (24) months prior to such determination date, (iii) was a Series E Designee, GFI
Designee, DBIC Designee, Oak Designee or Trimarc Designee, (iv) was nominated with the approval of a majority of the Continuing
Directors who were members of the Board at the time of such nomination or (v) was elected with the approval of holders of at least
a majority of the Series E Preferred Stock and Series E-2 Preferred Stock, voting together as a separate class.

    	2

    	 

    

 

(g)               
“Derivatives Transaction” means the sale, purchase or grant of any contract to purchase, contract to sell,
option, forward, swap, warrant, scrip, right to subscribe to, call or commitment of any character whatsoever or in any combination,
relating to, or securities or rights convertible into, or exercisable or exchangeable for, or the value of which is dependent
(in whole or in part) on the value of, any shares of capital stock of the Company, whether such transaction may be settled in
cash, securities or otherwise.

(h)              
“Market Sale” means any sale, transfer or other disposition of Securities in (i) a “brokers’ transaction”
(as defined in Rule 144 but excluding clause (4) of such definition for purposes hereof), or (ii) a Public Sale using a broker
and where clauses (1) and (3) of such definition of “brokers’ transaction” would be satisfied notwithstanding
that such transaction constitutes a Public Sale, in each case, occurring on an exchange or other recognized market (the “Market”)
where the average daily volume of the Company’s stock over the four week period preceding such transfer or other disposition
has been at least 50,000 shares; provided, however, that any sale, transfer or other disposition of Securities made
pursuant to Rule 144 shall not be deemed to be a “Market Sale.” 

(i)                
“Permitted Transferee” means: 

(i)                
as to any Stockholder who is a natural person, (A) the successors in interest to such Stockholder, in the case of a transfer
upon the death of such Stockholder, provided that such successors in interest would be a Permitted Transferee under clauses (i)(B)
or (i)(D) of this definition, (B) such Stockholder’s spouse, parents and descendants (whether by blood or adoption,
and including stepchildren) and the spouses of such persons, (C) such Stockholder, with respect to the disposition of the
community property interest of such Stockholder’s spouse in all or any part of the Securities upon the death of such spouse,
and any transfer occasioned by the incompetence of such Stockholder and (D) in the case of a transfer during such Stockholder’s
lifetime, any Person in which no Person has any interest (directly or indirectly) except for any of such Stockholder, such Stockholder’s
spouse, parents and descendants (whether by blood or adoption, and including stepchildren) and the spouses of such persons; provided,
however, that in respect of any transfer by any Stockholder during such Stockholder’s lifetime pursuant to clause
(B) or (D), such Stockholder shall retain voting power over all of the outstanding Shares being transferred;

(ii)              
as to any Stockholder that is a trust, all the beneficiaries of which are natural persons, such beneficiaries or the grantor of
the trust; provided, however, that if such trust is a Permitted Transferee under clause (i)(A) or (i)(D) of
this definition, each such beneficiary or grantor of such trust is a Person who would be permitted to have an interest in such
trust under such clause (i)(A) or (i)(D);

(iii)            
as to any Stockholder that is a limited partnership or limited liability company, (A) any limited or general partner, member,
officer, employee or affiliate of such Stockholder or (B) any affiliate of any limited or general partner or member of such
Stockholder; and

(iv)            
as to any Stockholder that is a corporation, all affiliates of such Stockholder.

(j)                
“Person” means an individual, corporation, partnership, limited partnership, trust, association or other legal
entity.

    	3

    	 

    

 

(k)              
“Preferred Securities” means the Series A Securities, the Series C Preferred Stock and the shares of Common
Stock issued to a Stockholder upon the conversion of shares of Series C Preferred Stock, the Series E Securities and the shares
of Common Stock issued to a Stockholder upon the conversion of shares of Series C Preferred Stock, Series E Preferred Stock, Series
E-1 Preferred Stock or Series E-2 Preferred Stock.

(l)                
“Private Sale” means any sale, transfer or other disposition of Securities by a Selling Stockholder that is
not a Market Sale or a Public Sale.

(m)            
“Public Sale” means (i) a primary sale of any equity securities of the Company by the Company pursuant to a
registration statement in which one or more Stockholders participates as a selling stockholder, or (ii) a secondary sale of equity
securities of the Company by Stockholders pursuant to a registration statement filed either by the Company for the benefit of
such Stockholders or by such Stockholders. For the avoidance of doubt, a Public Sale may also be a Market Sale if it satisfies
clause (ii) of the definition thereof.

(n)              
“Required Stockholders” means the holder(s) of at least 66.6% of the Series E Securities.

(o)              
“Rule 144” means Rule 144 (or any successor provisions) promulgated under the Securities Act of 1933, as amended.

(p)              
“Sales” means Private Sales, Public Sales and Market Sales, and includes Derivative Transactions.

(q)              
“Securities” means Shares and Warrants. 

(r)                
“Series A Preferred Stock” means the Series A Participating Preferred Stock, par value $0.0001 per share, of
the Company.

(s)               
“Series A Securities” means shares of Series A Preferred Stock and Warrants to purchase shares of Series A
Preferred Stock.

(t)                
“Series C Certificate of Designation” means that certain Certificate of Designation of Series C Convertible
Preferred Stock of the Company adopted by the Company and filed with the Delaware Secretary of State prior to the execution hereof.

(u)              
“Series C Preferred Stock” means the Series C Convertible Preferred Stock, par value $0.0001 per share, of
the Company.

(v)              
“Series E Certificate of Designation” means that certain Certificate of Designation of Series E Convertible
Preferred Stock, Series E-1 Convertible Preferred Stock and Series E-2 Convertible Preferred Stock of the Company adopted by the
Company and filed with the Delaware Secretary of State prior to the execution hereof.

    	4

    	 

    

(w)             
“Series E Preferred Stock” means the Series E Convertible Preferred Stock, par value $0.0001 per share, of
the Company.

(x)              
“Series E Securities” means shares of Series E Preferred Stock, Series E-1 Preferred Stock and Series E-2 Preferred
Stock and Warrants to purchase shares of Series E Preferred Stock, Series E-1 Preferred Stock or Series E-2 Preferred Stock.

(y)              
“Series E Stockholder” means each holder of Series E Securities. 

(z)               
“Series E-1 Preferred Stock” means the Series E-1 Convertible Preferred Stock, par value $0.0001 per share,
of the Company.

(aa)           
“Series E-2 Preferred Stock” means the Series E-2 Convertible Preferred Stock, par value $0.0001 per share,
of the Company

(bb)          
“Shares” means the shares of Series E Preferred Stock, Series E-1 Preferred Stock, Series E-2 Preferred Stock,
Series C Preferred Stock, Series A Preferred Stock and Common Stock.

(cc)           
“Warrants” means warrants and other rights issued by the Company to purchase shares of Common Stock, Series
A Preferred Stock, Series E Preferred Stock, Series E-1 Preferred Stock or Series E-2 Preferred Stock, as the case may be.

2.                 
Tag-Along Rights With Respect to Sales of Series E Preferred Stock, Series E-1 Preferred Stock and Series E-2 Preferred Stock.

(a)               
Tag-Along Rights.

(i)                
If, at any time after the date of this Agreement, a Series E Stockholder desires to sell or otherwise transfer, directly or indirectly,
through a Derivatives Transaction or otherwise, in a Private Sale 10% or more of the Series E Securities owned by such Series
E Stockholder as of the date of this Agreement (or, if the Series E Stockholder has joined this Agreement after the date hereof,
as of the date of such joinder) (a “Selling Stockholder”), then each of the Series E Stockholders shall have
the right to participate in the proposed Private Sale by such Selling Stockholder as provided in this Section 2(a). The Selling
Stockholder shall give written notice (the “Series E Tag-Along Notice”) to each of the Series E Stockholders
of each proposed Sale of such Series E Securities at least ten (10) days prior to the proposed effective date of such Private
Sale. The Tag-Along Notice shall set forth the terms and conditions of the Private Sale, including the number of Series E Securities
that the Selling Stockholder proposes to sell (the “Offered Series E Securities”), the proposed timing of such
Private Sale, the consideration to be paid for the Offered Series E Securities, the identity of the proposed purchaser, and all
other material terms and conditions of such Private Sale, including the proposed form of written agreement, if any. Each of the
other Series E Stockholders shall have the right to sell to such transferee(s) a portion of its Series E Securities equal to the
product of (A) the number of Series E Securities then held by such Series E Stockholder and (B) a fraction
(1) the numerator of which shall be the number of Offered Series E Securities, and (2) the denominator of which shall be the total
number of Series E Securities held as of the date of this Agreement by the Series E Stockholders (including the Selling Stockholder)
participating in such Sale (as adjusted for stock splits, combinations and the like and as reduced by any Sales previously made
by such Series E Stockholder(s) (including any that are Selling Stockholder(s)) subsequent to the date of this Agreement). 

    	5

    	 

    

 

(ii)              
Each Series E Stockholder that desires to exercise the tag-along rights to participate in the proposed Private Sale as provided
in this Section 2(a) (a “Series E Tagging Stockholder” and, collectively, the “Series E Tagging Stockholders”)
must exercise such tag-along rights within ten (10) days after its receipt of the Series E Tag-Along Notice, by delivery of a
written notice to the Selling Stockholder, with a copy to the Company, indicating such Series E Tagging Stockholder’s desire
to exercise its rights and specifying the number of Series E Securities (the “Tagging Series E Securities”)
it wishes to sell. The Tagging Series E Securities shall be in the same proportion of Shares and Warrants as the Offered Series
E Securities. The number of Series E Securities that the Selling Stockholder may sell pursuant to this Section 2 shall be reduced
by the equivalent amount of the Tagging Series E Securities, unless (A) the transferee(s) have indicated their willingness to
buy all of the Series E Securities that the Selling Stockholder and Series E Tagging Stockholders desire to sell, (B) the Company,
at its sole option, elects to redeem such Tagging Series E Securities or (C) the Selling Stockholder elects to purchase such Tagging
Series E Securities. At the closing of such Sale, each Series E Tagging Stockholder shall deliver (A) all documents required to
be executed in connection with such Private Sale and (B) the certificates for the Series E Securities being sold to the purchaser(s)
thereof against receipt of the purchase price therefor paid by certified or bank check or wire transfer.

(iii)            
In lieu of the transferee(s) purchasing the Tagging Series E Securities pursuant to this Section 2(a), (A) the Company may, at
its sole option, elect to redeem such Tagging Series E Securities at the same price per share as such transferee(s) would have
paid pursuant to the provisions of Section 2(a) and/or (B) the Selling Stockholder may elect to purchase such Tagging Series E
Securities at the same price per share as such transferee(s) would have paid pursuant to the provisions of Section 2(a). Any such
redemption by the Company or purchase by the Selling Stockholder shall be completed prior to or simultaneously with the proposed
Sale. 

(iv)            
If a Series E Tagging Stockholder properly exercises its tag-along rights under this Section 2(a) and the Tagging Series E Securities
are not (A) purchased by the purchaser of the Offered Series E Securities, (B) redeemed by the Company or (C) purchased by the
Selling Stockholder, then the Selling Stockholder shall not be permitted to consummate the proposed Sale of the Series E Securities,
and any such attempted Sale shall be null and void.

(v)              
Any notice given by a Series E Tagging Stockholder in which it elects to exercise its tag-along rights provided in this Section
2(a) shall be irrevocable and shall constitute a binding agreement to sell (to either the proposed transferee(s) or the Selling
Stockholder, as the case may be) or submit for redemption to the Company such Tagging Series E Securities as are included therein
on the terms and conditions applicable to such sale or redemption.

    	6

    	 

    

(b)              
Exclusions. The tag-along and redemption rights provided in this Section 2 shall not apply: (i) in the case of a transfer
to a Permitted Transferee, (ii) to a pledge that creates a mere security interest, provided that the pledgee thereof agrees in
writing in advance to be bound by and comply with all applicable provisions of this Agreement to the same extent as if it were
the Stockholder making such pledge, (iii) to any lien or pledge outstanding as of the date of this Agreement, (iv) to any sale,
transfer or other disposition of Securities pursuant to Rule 144 or (v) to a transfer of the Series C Preferred Stock pursuant
to the Beacon APA (as defined in Section 4(a)) (A) from the Company to the escrow agent, (B) from the escrow agent to the Company
or any of its affiliates or to Beacon (as defined in Section 4(a)) or any of its stockholders or (C) from Beacon to any of its
stockholders; provided that in the case of clause(s) (i) or (ii), the Stockholder shall deliver notice to each of
the Series E Stockholders of such pledge, gift or transfer and such Securities shall at all times remain subject to the terms
and restrictions set forth in this Agreement and such transferee shall, as a condition to such transfer or pledge, deliver a counterpart
signature page to this Agreement as confirmation that such transferee shall be bound by all the terms and conditions of this Agreement
as a Stockholder (but only with respect to the securities so transferred to the transferee). For the purposes of any calculation
in this Section 2 using the number of Series E Securities held as of the date of this Agreement, such calculations shall, for
a transferee pursuant to this Section 2(b), instead use the number of Series E Securities received by such transferee pursuant
hereto.

3.                 
Tag-Along Rights With Respect to Sales of Common Stock.

(a)               
Private Sales. 

(i)                
If, at any time after the date of this Agreement, a Stockholder desires to sell or otherwise transfer, directly or indirectly,
through a Derivatives Transaction or otherwise, in a Private Sale all or any portion of such Stockholder’s Common Securities
(a “Common Selling Stockholder”), then each holder of Preferred Securities shall have the right to participate
in the proposed Private Sale by such Common Selling Stockholder as provided in this Section 3(a). The Common Selling Stockholder
shall give written notice (the “Tag-Along Notice”) to each holder of Preferred Securities of each proposed
Private Sale of such Common Securities at least ten (10) days prior to the proposed effective date of such Private Sale. The Tag-Along
Notice shall set forth the terms and conditions of the Private Sale, including the number of Common Securities that the Common
Selling Stockholder proposes to sell (the “Offered Securities”), the proposed timing of such Private Sale,
the consideration to be paid for the Offered Securities, the identity of the proposed purchaser, and all other material terms
and conditions of the Private Sale, including the proposed form of written agreement, if any. Each holder of Preferred Securities
shall have the right to sell to such transferee(s) a portion of its Preferred Securities equal to the product of (A) the number
of Preferred Securities then held by such Stockholder and (B) a fraction (1) the numerator of which
shall be the number of Offered Securities, and (2) the denominator of which shall be the total number of Common Securities held
as of the date of this Agreement by the holders of Preferred Securities, including the Common Selling Stockholder participating
in such Sale (as adjusted for stock splits, combinations and the like and as reduced by any Sales previously made by such holder
of Preferred Securities and the Common Selling Stockholder subsequent to the date of this Agreement). The price per share
of Series A Preferred Stock to be paid by such transferee(s) shall be equal to one hundred (100) times the price to be paid by
such transferee(s) for each share of Common Stock (subject to equitable adjustment for stock splits,
combinations and the like that are made with respect to the Series A Preferred Stock where no corresponding adjustment
is made to the Common Stock). The price per share of Series C Preferred Stock to be paid by such transferee(s) shall be equal
to (X) the Conversion Shares (as defined in the Series C Certificate of Designation) divided by the number of shares of Series
C Preferred Stock issued and outstanding as of

    	7

    	 

    

 

the
Series C Original Issue Date (as defined in the Series C Certificate of Designation) times (Y) the price to be paid by such transferee(s)
for each share of Common Stock (subject to equitable adjustment for stock splits, combinations and
the like that are made with respect to the Series C Preferred Stock where no corresponding adjustment is made to the Common
Stock). The price per share of Series E Preferred Stock, Series E-1 Preferred Stock and Series E-2 Preferred Stock to be paid
by such transferee(s) shall be equal to the Conversion Rate (as defined in the Series E Certificate of Designation) times the
price to be paid by such transferee(s) for each share of Common Stock (subject to equitable adjustment
for stock splits, combinations and the like that are made with respect to the Series E Preferred Stock, Series E-1 Preferred
Stock or Series E-2 Preferred Stock, as applicable, where no corresponding adjustment is made to the Common Stock).

(ii)              
Each holder of Preferred Securities that desires to exercise the tag-along rights to participate in the proposed Private Sale
as provided in Section 2(a) (a “Preferred Tagging Stockholder” and, collectively, the “Preferred Tagging
Stockholders”) must exercise such tag-along rights within ten (10) days after its receipt of the Tag-Along Notice, by
delivery of a written notice to the Common Selling Stockholder, with a copy to the Company, indicating the desire of such Preferred
Tagging Stockholder to exercise its rights and specifying the number and series of Preferred Securities (the “Tagging
Securities”) it wishes to sell. The Tagging Securities shall be in the same proportion of Shares and Warrants as the
Offered Securities. The number of Common Securities that the Common Selling Stockholder may sell pursuant to this Section 3 shall
be reduced by the equivalent amount of the Tagging Securities, unless (A) the transferee(s) have indicated their willingness to
buy all of the Common Securities and Preferred Securities that the Common Selling Stockholder and Preferred Tagging Stockholders
desire to sell, (B) the Company, at its sole option, elects to redeem such Tagging Securities or (C) the Common Selling Stockholder
elects to purchase such Tagging Securities. At the closing of such Sale, each of the Preferred Tagging Stockholders shall deliver
(A) all documents required to be executed in connection with such Private Sale and (B) the certificates for the Tagging Securities
being sold to the purchaser(s) thereof against receipt of the purchase price therefor paid by certified or bank check or wire
transfer.

(iii)            
In lieu of the transferee(s) purchasing the Tagging Securities pursuant to this Section 3(a), (A) the Company may, at its sole
option, elect to redeem such Tagging Securities at the same price per share as such transferee(s) would have paid pursuant to
the provisions of Section 3(a) and/or (B) the Common Selling Stockholder may elect to purchase such Tagging Securities at the
same price per share as such transferee(s) would have paid pursuant to the provisions of Section 3(a). Any such redemption by
the Company or purchase by the Common Selling Stockholder shall be completed prior to or simultaneously with the proposed Sale.

(iv)            
If a Preferred Tagging Stockholder properly exercises its tag-along rights under this Section 3(a) and the Tagging Securities
are not (A) purchased by the purchaser of the Offered Securities, (B) redeemed by the Company or (C) purchased by the Common Selling
Stockholder, then the Common Selling Stockholder shall not be permitted to consummate the proposed Sale of the Common Securities,
and any such attempted Sale shall be null and void.

    	8

    	 

    

 

(v)              
Any notice given by a Preferred Tagging Stockholder in which it elects to exercise its tag-along rights provided in this Section
3(a) shall be irrevocable and shall constitute a binding agreement to sell (to either the proposed transferee(s) or the Common
Selling Stockholder, as the case may be) or submit for redemption to the Company such Tagging Securities as are included therein
on the terms and conditions applicable to such sale or redemption.

(b)              
Market Sales.

(i)                
If, at any time after the date of this Agreement, a Stockholder desires to sell or otherwise transfer, directly or indirectly,
through a Derivatives Transaction or otherwise, in a Market Sale all or any portion of such Stockholder’s Common Securities
(a “Market Selling Stockholder”) then each of the holders of Preferred Securities may request that the Company
redeem certain Preferred Securities held by such holder of Preferred Securities as provided in this Section 3(b), and the right
of the Market Selling Stockholder to sell or otherwise transfer any Common Securities in such Market Sale shall be subject to
the Company agreeing, at its sole option, to redeem such Preferred Securities pursuant to this Section 3(b). The Market Selling
Stockholder shall give written notice (the “Market Tag-Along Notice”) to each of the holders of Preferred Securities
and the Company of each proposed Market Sale at least one (1) Business Day prior to the proposed effective date of such Market
Sale, subject to the timing set forth in Section 3(b)(iii) below. The Market Tag-Along Notice shall set forth the terms and conditions
of the Market Sale, including the number of Offered Securities and the proposed timing of the Market Sale and the price per share
(the “Redemption Price”) at which the respective Preferred Securities will be redeemed (which, in the case
of (a) the Series A Securities shall be equal to one hundred (100) times the volume weighted average for shares of Common Stock
on the Market on the proposed date of such Market Sale (subject to equitable adjustment for stock splits,
combinations and the like that are made with respect to the Series A Preferred Stock where no corresponding adjustment
is made to the Common Stock), (b) the Series C Preferred Stock shall be equal to (X) the Conversion Shares (as defined in the
Series C Certificate of Designation) divided by the number of shares of Series C Preferred Stock issued and outstanding as of
the Series C Original Issue Date (as defined in the Series C Certificate of Designation) times (Y) the volume weighted average
for shares of Common Stock on the Market on the proposed date of such Market Sale (subject to equitable
adjustment for stock splits, combinations and the like that are made with respect to the Series C Preferred Stock where
no corresponding adjustment is made to the Common Stock) and (c) the Series E Securities shall be equal to Conversion Rate (as
defined in the Series E Certificate of Designation) times the volume weighted average for shares of Common Stock on the Market
on the proposed date of such Market Sale (subject to equitable adjustment for stock splits, combinations
and the like that are made with respect to the Series E Preferred Stock, Series E-1 Preferred Stock or Series E-2 Preferred
Stock, as applicable, where no corresponding adjustment is made to the Common Stock)). The Market Tag-Along Notice shall be delivered
by hand delivery to the addresses and confirmed telephonically to the individuals set forth on Schedule B hereto, as such
addresses and telephone numbers may be updated from time to time by each of the holders of Preferred Securities upon written notice
to the Company and the Stockholders.

    	9

    	 

    

 

(ii)              
If a Stockholder exercises its tag-along redemption rights in accordance with Section 3(b)(iii) below, such Stockholder shall
request the Company to redeem a portion of its Preferred Securities equal to the product of (A) the number of Preferred Securities
then held by such Stockholder and (B) a fraction (1) the numerator of which shall be the number of
Offered Securities, and (2) the denominator of which shall be the total number of Common Securities held as of the date of this
Agreement by the Market Selling Stockholder and the holders of Preferred Securities participating in such Sale (as adjusted for
stock splits, combinations and the like and as reduced by any Sales previously made by the Market Selling Stockholder and such
holders of Preferred Securities subsequent to the date of this Agreement).

(iii)            
If the Market Tag-Along Notice is delivered prior to 10 a.m. New York time, the tag-along redemption rights provided in this Section
3(b) must be exercised in respect of the Preferred Securities by the holders of Preferred Securities prior to 5 p.m., New York
time, on the date of the Market Tag-Along Notice and if the Market Tag-Along Notice is delivered at or after 10 a.m. New York
time, the tag-along redemption rights provided in this Section 3(b) must be exercised by the holders of Preferred Securities prior
to 5 p.m., New York time, on the Business Day following its receipt of the Market Tag-Along Notice. The tag-along redemption rights
shall be exercised by delivery of a written notice (the “Redemption Notice”) to the Market Selling Stockholder,
with a copy to the Company, indicating such Stockholder’s desire to exercise its rights and specifying the number and series
of Preferred Securities it requests to have the Company redeem. The Preferred Securities shall be in the same proportion of Shares
and Warrants as the Offered Securities. The Company must notify the Market Selling Stockholder and each of the holders of Preferred
Securities whether it agrees, in its sole option, to effect the requested redemption within the following applicable timeframe:
(A) if the Company receives such holder of Preferred Securities’ Redemption Notice at least two hours prior to 5 p.m., New
York time, on the date of the Redemption Notice, then it must provide such notification prior to 5 p.m., New York time, on such
date, or (B) if the Company receives such holder of Preferred Securities’ Redemption Notice less than two hours prior to
5 p.m. or after 5 p.m., New York time, on the date of the Redemption Notice, then it must provide such notification prior to 11:00
AM, New York time, on the Business Day following the date on which it received such Redemption Notice. If the Company agrees,
at its sole option, to redeem such Preferred Securities, it shall do so within four Business Days of the receipt by the Company
of the Redemption Notice at the price per share set forth in the Market Tag-Along Notice; provided, however, that if the Market
Selling Stockholder does not consummate the Market Sale set forth in the Market Tag-Along Notice, the Company shall not be required
to redeem the Preferred Securities and for the purposes of this Agreement, the Market Tag-Along Notice shall be treated as having
been withdrawn.

(iv)            
If a Stockholder properly exercises its tag-along redemption rights under this Section 3(b) and the Company does not agree to
redeem the Preferred Securities, then the Market Selling Stockholder may elect to purchase the Preferred Securities at a price
per share equal to the Redemption Price.

(v)              
If a Stockholder properly exercises its tag-along redemption rights under this Section 3(b) and (A) the Company does not agree
to redeem the Preferred Securities and (B) the Market Selling Stockholder does not elect to purchase such Preferred Securities,
then the Market Selling Stockholder(s) shall not be permitted to consummate the proposed Sale of the Common Securities, and any
such attempted Sale shall be null and void.

    	10

    	 

    

 

(vi)            
If a Stockholder properly exercises its tag-along redemption rights under this Section 3(b) and the Company agrees to redeem the
Preferred Securities but fails to do so for any reason, then the Market Selling Stockholder(s) shall, within two Business Days
of such failure by the Company, purchase the Preferred Securities at the Redemption Price.

(vii)          
Any notice given by a Stockholder in which it elects to exercise its tag-along redemption rights provided in this Section 3(b)
shall be irrevocable and shall constitute a binding agreement to submit for redemption or sell to the Market Selling Stockholder
such Preferred Securities as are included therein on the terms and conditions applicable to such redemption or sale.

(c)               
Public Sales. If at any time any Stockholder proposes a Public Sale that is not also a Market Sale (a “Subject
Public Sale”), the Company or such Stockholder, as the case may be, shall provide written notice (the “Offering
Notice”) of the Subject Public Sale to the holders of Preferred Securities at least twenty (20) Business Days prior
to the proposed effective date of the Subject Public Sale (the “Offering Date”), setting forth the anticipated
terms and conditions of the Subject Public Sale. Upon receipt of an Offering Notice, each holder of Preferred Securities may elect
to request that the Company redeem a portion of its Preferred Securities equal to the product of (i) the number of Preferred Securities
then held by such Stockholder and (ii) a fraction (A) the numerator of which shall be the number of
Common Securities to be sold by the Stockholder proposing such Public Sale (a “Public Sale Selling Stockholder”),
and (B) the denominator of which shall be the total number of Common Securities held by the Public Sale Selling Stockholder and
holders of Preferred Securities participating in such Sale as of the date of this Agreement (as adjusted for stock splits, combinations
and the like and as reduced by any Sales previously made by the Public Sale Selling Stockholder and such holders of Preferred
Securities). The redemption rights provided in this Section 3(c) must be exercised by such holder of Preferred Securities
within ten (10) Business Days of the delivery of the Offering Notice by delivering a written notice (an “Offering Redemption
Notice”) to the Company, with a copy to the Public Sale Selling Stockholder, stating the number and series of Preferred
Securities requested to be redeemed pursuant thereto. The Preferred Securities requested to be redeemed shall be in the same proportion
of Shares and Warrants as the Common Securities proposed to be sold in the Subject Public Sale. The redemption price per share
in the case of (a) the Series A Securities shall be equal to one hundred (100) times the price per share of Common Stock received
in the Public Sale by the Public Sale Selling Stockholder, before underwriter discounts or commissions (subject
to equitable adjustment for stock splits, combinations and the like that are made with respect to the Series A Preferred
Stock, where no corresponding adjustment is made to the Common Stock), (b) the Series C Preferred Stock shall be equal to (X)
the Conversion Shares (as defined in the Series C Certificate of Designation) divided by the number of shares of Series C Preferred
Stock issued and outstanding as of the Series C Original Issue Date (as defined in the Series C Certificate of Designation) times
(Y) the price per share of Common Stock received in the Public Sale by the Public Sale Selling Stockholder, before underwriter
discounts or commissions (subject to equitable adjustment for stock splits, combinations and the like
that are made with respect to the Series C Preferred Stock, where no corresponding adjustment is made to the Common Stock)
and (c) the Series E Securities shall be equal to Series E Conversion Rate, Series E-1 Conversion Rate or Series E-2 Conversion
Rate, as applicable

    	11

    	 

    

 

(as
such terms are defined in the Series E Certificate of Designation) times the price per share of Common Stock received in the Public
Sale by the Public Sale Selling Stockholder, before underwriter discounts or commissions (subject to
equitable adjustment for stock splits, combinations and the like that are made with respect to the Series E Preferred Stock,
Series E-1 Preferred Stock or Series E-2 Preferred Stock, where no corresponding adjustment is made to the Common Stock) (the
respective “Offering Redemption Price”). Upon receiving an Offering Redemption Notice pursuant to this Section
3(c), the Company shall have two (2) Business Days to notify the holders of Preferred Securities and the Public Sale Selling Stockholder
whether it will, at its sole option, redeem the Securities requested in the Offering Redemption Notice. If it agrees to redeem
such Securities, it shall also within such time frame set a date for redemption (the respective “Redemption Date”),
which date shall be no later than five (5) Business Days prior to the Offering Date. If the Company does not agree to redeem any
Preferred Securities subject to an Offering Redemption, then the Selling Stockholder may elect to purchase such Preferred Securities
at a price per share equal to the Offering Redemption Price. If (A) the Company does not agree to redeem any Preferred Securities
subject to an Offering Redemption and (B) the Public Sale Selling Stockholder does not elect to purchase such Preferred Securities,
or if after having so agreed, the Company fails to redeem or the Public Sale Selling Stockholder fails to purchase, any Preferred
Securities subject to an Offering Redemption Notice pursuant to this Section 3(c), the Public Sale Selling Stockholder(s) may
not consummate the Subject Public Sale. Any notice given by a Stockholder in which it elects to exercise its offering redemption
rights provided in this Section 3(c) shall be irrevocable and shall constitute a binding agreement to submit for redemption or
sell to the Public Sale Selling Stockholder such Preferred Securities as are included therein on the terms and conditions applicable
to such redemption or sale.

(d)              
Exclusions. The tag-along and redemption rights provided in this Section 3 shall not apply: (i) in the case of a transfer
to a Permitted Transferee, (ii) to a pledge that creates a mere security interest, provided that the pledgee thereof agrees in
writing in advance to be bound by and comply with all applicable provisions of this Agreement to the same extent as if it were
the Stockholder making such pledge, (iii) to any lien or pledge outstanding as of the date of this Agreement, (iv) to any sale,
transfer or other disposition of Securities pursuant to Rule 144, (v) to a transfer of the Series C Preferred Stock pursuant to
the Beacon APA (A) from the Company to the escrow agent, (B) from the escrow agent to the Company or any of its affiliates or
to Beacon or any of its stockholders or (C) from Beacon to any of its stockholders or (vi) to any sale, transfer or other disposition
of Securities following a Mandatory Conversion (as defined in the Series E Certificate of Designation); provided that
in the case of clause(s) (i) or (ii), the Stockholder shall deliver notice to the holders of Preferred Securities of such
pledge, gift or transfer and such Common Securities shall at all times remain subject to the terms and restrictions set forth
in this Agreement and such transferee shall, as a condition to such transfer or pledge, deliver a counterpart signature page to
this Agreement as confirmation that such transferee shall be bound by all the terms and conditions of this Agreement as a Stockholder
(but only with respect to the securities so transferred to the transferee). For the purposes of any calculation in this Section
3 using the number of Common Securities or Preferred Securities held as of the date of this Agreement, such calculations shall,
for a transferee pursuant to this Section 3(d), instead use the number of Securities received by such transferee pursuant hereto.

(e)               
Volume Exclusions. In addition to the exclusions set forth in Section 3(d) above, the tag-along rights and related obligations
of the Company with respect to redemptions provided in Sections 3(a), 3(b) and 3(c) shall not apply to Sales by a Stockholder
of up to 10% of the Common Securities held by such Stockholder as of the date that such Stockholder first became party to this
Agreement in any consecutive twelve month period. The following calculation shall be used in determining the percentage of a Stockholder’s
Common Securities that are being sold or otherwise transferred in any given Sale: (x) the number of Common Securities previously
sold pursuant to this Section 3(e) by such Stockholder and proposed to be sold by such Stockholder divided by (y) the
total number of Common Securities held by such Stockholder as of the date of this Agreement (as adjusted for stock splits, combinations
and the like).

    	12

    	 

    

 

4.                 
Preemptive Rights.

(a)               
If the Company or any of its Subsidiaries proposes to issue additional equity securities, including any warrants, options or other
rights to acquire equity of the Company or any of its subsidiaries or debt securities that are convertible into or exchangeable
or exercisable for equity securities of the Company or any of its Subsidiaries (with the exception of any issuance (i) in connection
with any acquisition of assets of another Person by the Company or any of its Subsidiaries, whether by purchase of stock, merger,
consolidation, purchase of all or substantially all of the assets of such Person or otherwise (excluding any issuance for purposes
of financing such transaction) approved by the Board and the requisite holders of the Series E Preferred Stock and Series E-2
Preferred Stock to the extent required under the Series E Certificate of Designation, (ii) Exempted Securities (as such term is
defined in the Series E Certificate of Designation), (iii) in an underwritten public offering resulting in gross proceeds of at
least $50,000,000 and at a price per share pursuant to which the Company’s market capitalization would be at least $175,000,000
and (iv) approved by holders of the majority of the Series E Preferred Stock and Series E-2 Preferred Stock, voting as a separate
class (in each case, having been approved in accordance with the terms of this Agreement and the Series E Certificate of Designation,
to the extent applicable)) (“Preemptive Securities”), the Company shall provide written notice (an “Issuance
Notice”) to each holder of Preferred Securities of such anticipated issuance no later than twenty-two (22) Business
Days prior to the anticipated issuance date. Such notice shall set forth the principal terms and conditions of the issuance, including
a description of the Preemptive Securities proposed to be issued, the proposed purchase price for such Preemptive Securities and
the anticipated issuance date. Each holder of Preferred Securities shall have the right to purchase a number of Preemptive Securities
determined by multiplying (i) the number of Preemptive Securities proposed to be issued, by (ii) a fraction, the numerator of
which is the number of shares of Preferred Stock held by such Stockholder on an as-converted basis at the time the Issuance Notice
for such Preemptive Securities is given and the denominator of which is the total number of shares of the Company’s Common
Stock issued and outstanding on a fully-diluted, as converted, basis on the date of the Issuance Notice (the “Pro Rata
Portion”). Each holder of Preferred Securities that desires to purchase Preemptive Securities at the price and on the
terms and conditions specified in the Company’s notice must deliver an irrevocable written
notice to the Company (a “Preemptive Exercise Notice”) no later than ten (10) Business Days after the
delivery of the Issuance Notice, setting forth (x) the number of such Preemptive Securities for which such right is exercised
(which such number shall not exceed such Stockholder’s Pro Rata Portion of such Preemptive Securities) and (y) the maximum
number of additional Preemptive Securities that such Stockholder would be willing to purchase in excess of such Stockholder’s
Pro Rata Portion in the event that any other Stockholder or other Person entitled to exercise preemptive rights with respect to
such issuance elects not to purchase its full Pro Rata Portion of such Preemptive Securities. 

(b)              
In the event the Stockholders with preemptive rights pursuant to clause (a) above do not purchase all such Preemptive Securities
in accordance with the procedures set forth in such clause (a), the Company shall have one hundred twenty (120) days after the
anticipated issuance date to sell to other Persons the remaining Preemptive Securities at the price and on such terms and conditions
that are no more favorable to such other Persons than those specified in the Company’s notices to the Stockholders pursuant
to Section 4(a). If the Company fails to sell such Preemptive Securities within one hundred twenty (120) days of the anticipated
issuance date provided in the notices given to the Stockholders pursuant to Section 4(a), the Company shall not thereafter issue
or sell any Preemptive Securities without first offering such Preemptive Securities to the holders of Preferred Securities
in the manner provided in this Section 4.

    	13

    	 

    

 

(c)               
The election by a Stockholder not to exercise its preemptive rights under this Section 4 in any one instance shall not affect
such Stockholder’s right (other than in respect of a reduction in its Pro Rata Portion) as to any future issuances under
this Section 4.

(d)              
All costs and expenses incurred by the Company in connection with its obligations under this Section 4, including all attorneys
fees and charges, all accounting fees and charges and all finders, brokerage or investment banking fees, charges or commissions,
shall be paid by the Company.

(e)               
Notwithstanding any provision hereof to the contrary, in lieu of complying with the provisions of this Section 4, the Company
may elect to give the Issuance Notice to the Stockholders with preemptive rights pursuant to Section 4(a) within ten (10) days
after the issuance of Preemptive Securities and thereafter give such Stockholders the right to purchase such number of Preemptive
Securities as would provide them with the same ownership as if the Issuance Notice and preemptive rights had been provided prior
to the issuance of the Preemptive Securities, all on the same terms and conditions as would otherwise apply under this Section
4. 

(f)               
The preemptive rights under this Section 4 shall terminate on such date as of which less than 25% of the shares of Series E Preferred
Stock and Series E-2 Preferred Stock collectively issued in the Transactions remain outstanding.

5.                 
Certain Sales. At any time on or after December 5, 2016, to the extent a Stockholder holds any Preferred Securities (the
“Remaining Securities”), such Stockholder may provide notice to the Company of its desire to sell all or any
portion of the Remaining Securities. Upon receipt of such notice, the Company will use its commercially reasonable efforts to
assist such Stockholder in facilitating a sale, transfer or other disposition of the Remaining Securities (which, for avoidance
of doubt, shall not include any obligation to pursue or consummate a Change of Control). Alternatively, upon receipt of such notice,
the Company may, at its sole option, redeem the Remaining Securities at a price per share equal to (x) the number of shares of
Common Stock into which a share of the Remaining Securities would be convertible pursuant to the certificate of designation relating
to such series of Shares, multiplied by (y) the fair market value of a share of Common Stock as determined in accordance
with the terms of the certificate of designation relating to such series of Shares.

6.                 
No Mandatory Redemption. For the avoidance of doubt and notwithstanding anything to the contrary herein, any redemption
of Shares or other securities by the Company referenced herein shall not be mandatory and shall be made only at the Company’s
sole and exclusive option, unless and then only to the extent specifically agreed to by the Company (at its sole and exclusive
option) in writing in response to a redemption request made under this Agreement.

    	14

    	 

    

 

7.                 
Series E, Oak, DBIC, GFI Board and Trimarc Designees. 

(a)               
For so long as the Stockholders set forth on Schedule C hereto (the “Series E Designee Holders”) collectively
own (within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”))
at least (A) 25% of the Series E Preferred Stock and/or Series E-2 Preferred Stock issued in the Transactions or (B) in the event
of a conversion of the Series E Preferred Stock and/or Series E-2 Preferred Stock, 25% of the Common Stock underlying the Series
E Preferred Stock and/or Series E-2 Preferred Stock, as applicable, issued in the Transactions, (i) the Company will nominate
and use its reasonable best efforts to cause to be elected and cause to remain a director on the Board and (ii) each Stockholder,
at each annual meeting of the stockholders of the Company, or at any meeting of the stockholders of the Company at which members
of the Board are to be elected, or whenever members of the Board are to be elected by written consent, agrees to vote or act with
respect to all shares of voting capital stock of the Company registered in its name or beneficially owned by it as of the date
hereof and any and all securities of the Company legally or beneficially acquired by such Stockholder after the date hereof, so
as to elect, and not to vote to remove, one person designated in writing collectively by the Series E Designee Holders (the “Series
E Designee”). Subject to the following sentence, the consent of each of the Series E Designee Holders holding at least
8% of the outstanding shares of Series E Preferred Stock or Series E-2 Preferred Stock as of the date hereof, as set forth on
Schedule C hereto (each, an “8% Series E Designee Holder”), shall be required in respect of the designation
of the Series E Designee, for so long as such 8% Series E Designee Holder shall hold at least 25% of the shares of Series E Preferred
Stock and/or Series E-2 Preferred Stock it acquired as of the date hereof. Notwithstanding the foregoing, for so long as Oak continues
to own at least 25% of the shares of Series E Preferred Stock acquired by it in the Initial Purchase and Exchange Transactions
(or, in the event of a conversion of the Series E Preferred Stock, 25% of the Common Stock underlying the Series E Preferred Stock
it acquired in the Initial Purchase and Exchange Transactions), the Series E Designee shall be designated by Oak in its sole discretion,
and in such event Oak shall be deemed to be the “Series E Designee Holders.” 

(b)              
Subject to applicable law and the rules and regulations of the Securities and Exchange Commission and any securities exchange
or quotation system on which the Company’s securities are listed or quoted, the 8% Series E Designee Holders shall have
the right to require that the Series E Designee be a member of each principal committee of the Board.

(c)               
For so long as Oak continues to own at least 25% of the shares of Series E Preferred Stock or Series E-2 Preferred Stock acquired
by it in the Initial Purchase and Exchange Transactions (or, in the event of a conversion of the Series E-1 Preferred Stock or
Series E-2 Preferred Stock, 25% of the Common Stock underlying the Series E Preferred Stock or Series E-2 Preferred Stock it acquired
in the Initial Purchase and Exchange Transactions), (i) the Company will nominate and use its reasonable best efforts to cause
to be elected and cause to remain a director on the Board and (ii) each Stockholder, at each annual meeting of the stockholders
of the Company, or at any meeting of the stockholders of the Company at which members of the Board are to be elected, or whenever
members of the Board are to be elected by written consent, agrees to vote or act with respect to all shares of voting capital
stock of the Company registered in its name or beneficially owned by it as of the date hereof and any and all securities of the
Company legally or beneficially acquired by such Stockholder after the date hereof, so as to elect, and not to vote to remove,
two people designated by Oak (the “Oak Designees”), which Oak Designees shall, for the avoidance of doubt,
be in addition to Oak’s rights in respect of the Series E Designee pursuant to Section 7(a) hereof.

    	15

    	 

    

 

(d)              
For so long as DBIC and/or Mida continue to own, in the aggregate, at least 25% of the shares of Series E-2 Preferred Stock acquired
by them in the Initial Series E-2 Transactions (or, in the event of a conversion of the Series E-2 Preferred Stock, 25% of the
Common Stock underlying the Series E-2 Preferred Stock they acquired in the Initial Series E-2 Transactions), (i) the Company
will nominate and use its reasonable best efforts to cause to be elected and cause to remain a director on the Board and (ii)
each Stockholder, at each annual meeting of the stockholders of the Company, or at any meeting of the stockholders of the Company
at which members of the Board are to be elected, or whenever members of the Board are to be elected by written consent, agrees
to vote or act with respect to all shares of voting capital stock of the Company registered in its name or beneficially owned
by it as of the date hereof and any and all securities of the Company legally or beneficially acquired by such Stockholder after
the date hereof, so as to elect, and not to vote to remove, three people jointly designated by DBIC and Mida (or, in the event
one of them no longer owns any shares of Series E-2 Preferred Stock acquired by them in the Initial Series E-2 Transactions (or
the Common Stock underlying such Series E-2 Preferred Stock), then the other shall designate such three people) (the “DBIC
Designees”). 

(e)               
For so long as GFI continues to own at least 25% of the shares of Series E Preferred Stock or Series E-2 Preferred Stock acquired
by it in the Initial Purchase and Exchange Transactions (or, in the event of a conversion of the Series E Preferred Stock or Series
E-2 Preferred Stock, 25% of the Common Stock underlying the Series E Preferred Stock or Series E-2 Preferred Stock it acquired
in the Initial Purchase and Exchange Transactions), (i) the Company will nominate and use its reasonable best efforts to cause
to be elected and cause to remain a director on the Board and (ii) each Stockholder, at each annual meeting of the stockholders
of the Company, or at any meeting of the stockholders of the Company at which members of the Board are to be elected, or whenever
members of the Board are to be elected by written consent, agrees to vote or act with respect to all shares of voting capital
stock of the Company registered in its name or beneficially owned by it as of the date hereof and any and all securities of the
Company legally or beneficially acquired by such Stockholder after the date hereof, so as to elect, and not to vote to remove,
one person designated by GFI (the “GFI Designee”). 

(f)               
For so long as Trimarc continues to own at least 25% of the shares of Series E-2 Preferred Stock acquired by it in the February
2013 Series E-2 Transaction (or, in the event of a conversion of the Series E-2 Preferred Stock, 25% of the Common Stock underlying
the Series E-2 Preferred Stock it acquired in the February 2013 Series E-2 Transaction), (i) the Company will nominate and use
its reasonable best efforts to cause to be elected and cause to remain a director on the Board and (ii) each Stockholder, at each
annual meeting of the stockholders of the Company, or at any meeting of the stockholders of the Company at which members of the
Board are to be elected, or whenever members of the Board are to be elected by written consent, agrees to vote or act with respect
to all shares of voting capital stock of the Company registered in its name or beneficially owned by it as of the date hereof
and any and all securities of the Company legally or beneficially acquired by such Stockholder after the date hereof, so as to
elect, and not to vote to remove, one person designated by Trimarc (the “Trimarc Designee”). 

(g)               
It shall be a condition precedent to the Company’s obligations under Sections 7(a), (c), (d), (e) and (f), respectively,
that (i) the Series E Designee Holders and the Series E Designee, Oak and the Oak Designees, DBIC, Mida and the DBIC Designees,
GFI and the GFI Designee, and Trimarc and the Trimarc Designee, respectively, shall timely furnish to the Company such information
regarding the Series E Designee Holders and the Series E Designee, Oak and the Oak Designees, DBIC, Mida, and the DBIC Designees,
GFI and the GFI Designee, and Trimarc and the Trimarc Designee, respectively, as shall be reasonably necessary for the Company
to comply with its disclosure and other obligations under applicable law and the rules and regulations of the Securities and Exchange
Commission and any securities exchange or quotation system on which the Company’s securities are listed or quoted, (ii)
the Series E Designee Holders, Oak, DBIC, Mida, GFI, and Trimarc, respectively, shall comply with applicable law and the rules
and regulations of the Securities and Exchange Commission with respect to their right to designate the Series E Designee, the
Oak Designees, the DBIC Designees, the GFI Designee and the Trimarc Designee, respectively, and (iii) the Series E Designee, Oak
Designees, DBIC Designees, the GFI Designee and the Trimarc Designee, respectively, shall comply with applicable law and the rules
and regulations of the Securities and Exchange Commission with respect to his or her membership on the Board.

    	16

    	 

    

 

(h)              
In addition to the foregoing rights set forth in this Section 7, so long as any Stockholder (other than Jefferies) holding at
least 8% of the outstanding shares of Series E Preferred Stock, Series E-1 Preferred Stock or Series E-2 Preferred Stock as of
the date hereof owns at least 25% of the shares of Series E Preferred Stock, Series E-1 Preferred Stock or Series E-2 Preferred
Stock, respectively, acquired by it in the Initial Purchase and Exchange Transactions, such Stockholder shall have the right to
appoint one non-voting representative to attend each meeting of the Board and each committee thereof (an “Investor Observer”).
Each Investor Observer will be entitled to receive copies of all notices, minutes, consents and other materials and information
that the Company provides to the Board; provided that (a) the Investor Observer shall execute a confidentiality agreement in a
form reasonably acceptable to the Company and the investor designating such Investor Observer, and (b) the Company may require
such Investor Observer to be recused from any meeting and may redact such materials on advice of counsel in connection with matters
involving the attorney-client privilege or conflicts of interest.

(i)                
Each Stockholder agrees to vote, or cause to be voted, all voting Shares owned by such Stockholder, or over which such Stockholder
has voting control, from time to time and at all times, in whatever manner as shall be necessary to ensure that the size of the
Board shall be set and remain at no more than eleven directors.

(j)                
The provisions of Section 7(i) shall terminate and be of no further force or effect on the date immediately prior to the date,
if any, on which shares of Common Stock are listed on the New York Stock Exchange, the NYSE Amex, the NASDAQ Stock Market or any
successor to any of the foregoing.

(k)              
For so long as Jefferies & Company, Inc. (“Jefferies”) owns at least twenty-five percent (25%) of the shares
of Series E Preferred Stock acquired in connection with the Exchange Transaction, Jefferies shall be entitled to appoint two (2)
non-voting representatives to attend each meeting of the Company’s Board of Directors and each committee thereof (the “Jefferies
Observers”). The Jefferies Observers will be entitled to receive copies of all notices, minutes, consents and other
materials and information that the Company provides to the Board; provided that (a) the Jefferies Observers shall execute a confidentiality
agreement in a form reasonably acceptable to the Company and Jefferies, and (b) the Company may require the Jefferies Observers
to be recused from any meeting and may redact such materials on advice of counsel in connection with matters involving the attorney-client
privilege or conflicts of interest. Such observer rights in this Section 7(k) supersede and are in lieu of all other observer
rights granted to Jefferies prior to the date hereof. 

8.                 
Affirmative Covenant. If any Applicable Action is required to be approved pursuant to Section 4(e) of the Series E Certificate
of Designation and is approved pursuant to Section 4(e) of the Series E Certificate of Designation, then Oak and any other Stockholder
who owns, beneficially or of record, shares of Series C Preferred Stock shall (a) provide an affirmative vote or written consent
(with respect to all shares of Series C Preferred Stock held of record or beneficially by them or over which they exercise voting
control) for such Applicable Action pursuant to Section 4(d) of the Series C Certificate of Designation, or (b) in lieu of the
affirmative vote or written consent contemplated by the foregoing clause (a), provide an affirmative vote or written consent (with
respect to all shares of Series C Preferred Stock held of record or beneficially by them or over which they exercise voting control)
to waive the provisions of Section 4(d) of the Series C Certificate of Designation (pursuant to Section 11 of the Series C Certificate
of Designation) with respect to such Applicable Action. As used herein, the term “Applicable Action” means
any action with respect to which the Company is required to obtain the affirmative vote or written consent of any holders Series
C Preferred Stock pursuant to Section 4(d) of the Series C Certificate of Designation (whether together as a single class with
the holders of Series D Preferred Stock and Series D-1 Preferred Stock or acting on their own due to the Series D Preferred Stock
and Series D-1 Preferred Stock not being entitled to participate in such affirmative vote or written consent for any reason).

    	17

    	 

    

 

9.                 
Miscellaneous.

(a)               
Notices. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this
Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon
receipt, when sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on
file by the sending party); or (iii) one business day after deposit with an overnight courier service prior to such service’s
deadline for next-business day delivery to the recipient (all delivery charges prepaid), in each case properly addressed to the
party to receive the same. The addresses and facsimile numbers for such communications shall be:

	If
        to the Company:

         

	Bonds.com
Group, Inc.

                                                          1500
Broadway, 31st Floor

                                                          New York, New York 10036

        Facsimile:
        (212) 278-8934

        Attention:
        Thomas Thees, Chief Executive Officer

         

	with
        a copy (for informational purposes only) to:

         

	Hill
        Ward Henderson

        3700
        Bank of America Plaza

        101
        East Kennedy Boulevard, Suite 3700

        Tampa,
        Florida 33602

        Facsimile:
        (813) 221-2900

        Attention:
        Mark A. Danzi, Esq.

 

If
to any Stockholder, at the address and facsimile number set forth on Schedule A hereto,

or
to such other address, facsimile number and/or email address and/or to the attention of such other Person as the recipient party
has specified by written notice given to each other party five (5) days prior to the effectiveness of such change. Written confirmation
of receipt (A) given by the recipient of such notice, consent, waiver or other communication, (B) mechanically or electronically
generated by the sender’s facsimile machine containing the time, date, recipient facsimile number and an image of the first
page of such transmission or (C) provided by an overnight courier service shall be rebuttable evidence of personal service, receipt
by facsimile or receipt from an overnight courier service in accordance with clause (i), (ii) or (iii) above, respectively.

    	18

    	 

    

 

(b)              
Further Instruments and Actions. The Company and each Stockholder shall execute such further instruments and take such
further action as may reasonably be necessary to carry out the intent of this Agreement and to enforce rights and obligations
pursuant hereto. No Stockholder shall vote any Shares, or take any other action, that would defeat, impair, be inconsistent with
or adversely affect the stated intentions of the parties under this Agreement.

(c)               
Additional Stockholders. Notwithstanding anything to the contrary contained herein, if after the date hereof
any person or entity acquires Series A Securities or Series E Securities, the Company shall use its reasonable best efforts to
have such stockholder become a party to this Agreement by executing and delivering an additional counterpart signature page to
this Agreement and such stockholder shall thereafter be deemed a “Stockholder” for all purposes hereunder. In addition,
the Company will not issue any Series E Securities unless the purchaser thereof becomes a party to this Agreement by executing
and delivering an additional counterpart signature page to this Agreement and such stockholder shall thereafter be deemed a “Stockholder”
for all purposes hereunder. No action or consent by the Stockholders shall be required for such joinder to this Agreement by such
additional stockholder(s), so long as such additional stockholder has agreed in writing to be bound by all of the obligations
of a “Stockholder” hereunder.

(d)              
Successors and Assigns. This Agreement and the rights and obligations of the parties hereunder shall inure to the benefit
of, and be binding upon, their respective successors, assigns and legal representatives. The rights of the Stockholders hereunder
are only assignable or transferable in connection with the transfer of any shares held by such Stockholder. The rights of UBS
hereunder shall only be transferable to an affiliate of UBS. 

(e)               
Governing Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation
of this Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law
or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action
or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served
in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.  EACH PARTY HEREBY IRREVOCABLY
WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION
WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

    	19

    	 

    

 

(f)               
Counterparts. This Agreement may be executed in two or more identical counterparts, all of which shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other
party; provided that a facsimile signature or a signature transmitted by email shall be considered due execution and shall be
binding upon the signatory thereto with the same force and effect as if the signature were an original, not a facsimile or emailed
signature.

(g)               
Headings. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation
of, this Agreement.

(h)              
Severability. If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable
by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed
amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such
provision shall not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified
continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the
prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective
expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred
upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s)
with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable
provision(s).

(i)                
Entire Agreement; Amendments. This supersedes all other prior oral or written agreements between the Company, the Stockholders,
their affiliates and Persons acting on their behalf with respect to the matters discussed herein (including, without limitation,
the Original Agreement (as amended by the Amendment)), and this Agreement contains the entire understanding of the parties with
respect to the matters covered herein and therein. No provision of this Agreement may be amended or waived other than by an instrument
in writing signed by the Company and the Required Stockholders. Notwithstanding the foregoing, no amendment to this Agreement
shall disproportionately and adversely affect the rights of any Stockholder relative to the rights of all of the Stockholders
without such affected Stockholder’s consent.

(j)                
No Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

(k)              
Injunctive Relief. Without limiting the right of any party to seek any remedy available to such party for the breach or
threatened breach of this Agreement, the parties agree that injunctive relief may be sought by any party to enjoin any breach
or threatened breach of this Agreement without having to prove irreparable harm or actual damages and each party hereto waives
any defense to any such action for injunctive relief that there is an adequate remedy at law for such breach or threatened breach.

(l)                
Copies of this Agreement. The Company shall supply, free of charge, a copy of this Agreement to any Stockholder upon written
request from such Stockholder to the Company at its principal office.

    	20

    	 

    

(m)            
Termination. The provisions of this Agreement shall terminate upon the earlier to occur of (i) the date that the Stockholders
no longer own any Shares or (ii) a Change of Control pursuant to which Preferred Securities are treated in accordance with Section
3 of the Series E Certificate of Designation; provided, however, that one or more provisions of this Agreement may terminate
earlier pursuant to the terms thereof.

[The
remainder of this page has been intentionally left blank.]

 

 

    	21

    	 

    

IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

 

	 	 	BONDS.COM
    GROUP, INC.
	 	 	 
	 	 	By:	/s/
    Thomas Thees     
	 	 	Name:	 Thomas Thees
	 	 	Title:	 Chief
    Executive Officer

 

    	[Signature Page to A&R
                                                                                                                                                                                               Series E Stockholders’ Agreement]

    	 

    

 

IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

 

	 	 	GFINET
    INC.
	 	 	 
	 	 	By:	/s/
    J.C. Giancarlo     
	 	 	Name:	 J.C. Giancarlo
	 	 	Title:	 Executive
    Vice President

 

    	[Signature Page to A&R Series E Stockholders' Agreement]

    	 

    

IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

	 	 	OAK
    INVESTMENT PARTNERS XII,
	 	 	LIMITED
    PARTNERSHIP
	 	 	By:	Oak
Associates XII, LLC,
	 	 	 	its
General Partner
	 	 	 	 
	 	 	By:	/s/
    Ann H. Lamont
	 	 	Name:	 Ann
    H. Lamont
	 	 	Title:	 Managing Member

 

    	[Signature Page to A&R Series E Stockholders' Agreement]

    	 

    

 

 

IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

 

	 	 	DAHER
BONDS INVESTMENT COMPANY
	 	 	 
	 	 	By:	/s/
    Michel Daher     
	 	 	Name:	 Michel Daher
	 	 	Title:	 Chairman

    	[Signature Page to A&R Series E Stockholders' Agreement]

    	 

    

IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

 

	 	 	MIDA
HOLDINGS
	 	 	 
	 	 	By:	/s/
    Michel Daher     
	 	 	Name:	Michel Daher
	 	 	Title:	Chairman

 

 

    	[Signature Page to A&R Series E Stockholders' Agreement]

    	 

    

 

IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

 

		 	TRIMARC
CAPITAL FUND, L.P.
	 	 	 
	 	 	By:	Oakum Bay Trimarc Partners, LLC
	 	 	 	Its
General Partner
	 	 	 	 
	 	 	By:	/s/
    Michael Trica
	 	 	Name:	Michael Trica
	 	 	Title:	Managing Member

 

 

    	[Signature Page to A&R Series E Stockholders' Agreement]

    	 

    

 

Schedule
A

Stockholders

 

Stockholder
Name and Notice Address

 

UBS
Americas Inc.

 

677 Washington
Boulevard

Stamford, CT 06901

Telephone: (203) 719-5427

Facsimile: (203) 719-5627

Attention: Head of Traded Products - Legal

 

with
a copy (for informational purposes only) to:

 

Bingham
McCutchen LLP

399 Third Avenue

New York, New York 10022

Telephone: (212) 705-7278

Facsimile: (212) 702-3645

Attention: Kenneth A. Kopelman, Esq.

 

ROBERT
JONES

 

20 Friar
Tuck Circle

Summit,
NJ 07901

 

BONDS
MX, LLC

 

c/o Laidlaw
& Company (UK) Ltd.

90 Park
Avenue, 31st floor

New York,
New York 10016

Facsimile:
(212) 297-0670

Attention:
Hugh Regan

 

with a
copy (for informational purposes only) to:

 

Gibson,
Dunn & Crutcher LLP

2029 Century
Park East

Los Angeles,
California 90067-3026

Facsimile:
(310) 552-7038

Attention:
Mark Lahive

 

GFINET
INC.

c/o GFI
Group Inc.

55 Water
Street

New York,
NY 10041

Attn:General
Counsel

Telecopy:
(212) 968-2965

 

    	Schedule A - Page 1

    	 

    

with a
copy (for informational purposes only) to:

 

Willkie
Farr & Gallagher LLP

787 Seventh
Avenue

New York,
New York 10019

Attn:
Jeffrey R. Poss, Esq.

Telecopy:
(212) 728-9536

 

OAK INVESTMENT
PARTNERS XII, LIMITED PARTNERSHIP

 

901 Main
Street

Suite
600

Norwalk, Connecticut 06851

Fax No.: (203) 222-6941

Attn: Ann H. Lamont

 

with a
copy (for informational purposes only) to:

 

Finn Dixon
& Herling LLP

177 Broad Street

Stamford, Connecticut 06901

Fax No.: (203) 325-5001

Attn: Michael J. Herling

 

PLOUGH
PENNY PARTNERS, L.P.

 

270 Lafayette
Street, Ste. 1301

New York,
NY 10012

Attention:
Judson Traphagen

 

RICHARD
B. COONS IRA

 

191 Cat
Rock Road

Cos Cob,
CT 06807

Fax No.:
(216) 754-8457

 

JEFFERIES
& COMPANY, INC.

 

520 Madison
Avenue

New York,
New York 10022

Fax No.:
646-786-5044

Attention:
David Wong, SVP – Corporate Controller

 

With a
copy (for informational purposes only) to:

 

Cahill
Gambino, LLP

405 Lexington
Avenue, 7th FL

New York,
New York 10174

Fax No.:
(518) 584-1962

Attention:
David G. Nichols, Jr.

 

    	Schedule A - Page 2

    	 

    

 

 

DAHER
BONDS INVESTMENT COMPANY

 

c/o Delta
Trading

P.O. Box
241

Ferzol
Main Road

Bekaa
Valley, Lebanon

 

With a
copy (for informational purposes only) to:

 

Golenbock
Eiseman Assor Bell & Peskoe LLP

437 Madison
Avenue

New York,
New York 10022

Fax No.:
(212) 907-7385

Attention:
Andrew Peskoe

 

MIDA HOLDINGS

 

c/o Delta
Trading

P.O. Box
241

Ferzol
Main Road

Bekaa
Valley, Lebanon

 

With a
copy (for informational purposes only) to:

 

Golenbock
Eiseman Assor Bell & Peskoe LLP

437 Madison
Avenue

New York,
New York 10022

Fax No.:
(212) 907-7385

Attention:
Andrew Peskoe

 

XOL HOLDING
S.A.L.

 

Attn: President

Dedeian
Building 1st Floor

Naher Al
Mout Street, Metn

Lebanon

Tel +961-3-777256

 

with copies
to (which shall not constitute notice):

 

Tarter Krinsky
& Drogin LLP

1350 Broadway,
11th Floor

New York,
NY 10018

Attention: 
James G. Smith, Esq.

Tel: (212)
216-8000

Fax: (212)
216-8001

jsmith@tarterkrinsky.com

 

Hendrik
Jan Iwema

 

Drielander
8

8253  B2
 Dronten

Holland

 

TRIMARC
CAPITAL FUND, L.P.

 

400 Madison
Avenue, Suite 9D

New York,
NY 10017

Fax: (646)
607-9008

Attention:
Michael Trica 

    	Schedule A - Page 3

    	 

    

 

Schedule
B

Notice
Addresses for Tag-Along Notice

UBS
Americas Inc.

677 Washington
Blvd.

Stamford,
CT 06901

Attention: Head
of Strategic Investments for Equities and Fixed Income

 

UBS
Americas Inc.

100 Liverpool
St.

EC2M 2RH
London, UK

Attention:
Head of Global eBusiness, Fixed Income

 

UBS
Americas Inc.

677
Washington Boulevard

Stamford, CT 06901

Attention: Head of Traded Products - Legal

Bingham
McCutchen LLP 

399 Third Avenue

New York, New York 10022

Attention: Kenneth A. Kopelman, Esq.

 

ROBERT
JONES

20 Friar
Tuck Circle

Summit,
NJ 07901

 

BONDS
MX, LLC

c/o Laidlaw
& Company (UK) Ltd.

90 Park
Avenue, 31st floor

New York,
New York 10016

Facsimile:
(212) 297-0670

Attention:
Hugh Regan

 

Gibson,
Dunn & Crutcher LLP

2029 Century
Park East

Los Angeles,
California 90067-3026

Facsimile:
(310) 552-7038

Attention:
Mark Lahive

 

GFINET
INC.

c/o GFI
Group Inc.

55 Water
Street

New York,
NY 10041

Attn:General
Counsel

Telecopy:
(212) 968-2965

    	Schedule B - Page 1

    	 

    

 

 

Willkie
Farr & Gallagher LLP

787 Seventh
Avenue

New York,
New York 10019

Attention:
Jeffrey R. Poss, Esq.

Telecopy:
(212) 728-9536

 

OAK INVESTMENT
PARTNERS XII, LIMITED PARTNERSHIP

901
Main Street, Suite 600

Norwalk, Connecticut 06851

Fax No.: (203) 222-6941

Attn: Ann H. Lamont

Finn
Dixon & Herling LLP

177 Broad Street

Stamford, Connecticut 06901

Fax No.: (203) 325-5001

Attn: Michael J. Herling

PLOUGH
PENNY PARTNERS, L.P.

270 Lafayette
Street, Ste. 1301

New York,
NY 10012

Attention:
Judson Traphagen

 

RICHARD
B. COONS IRA

191 Cat
Rock Road

Cos Cob,
CT 06807

Fax No.:
(216) 754-8457

 

JEFFERIES
& COMPANY, INC.

520 Madison
Avenue

New York,
New York 10022

Fax No.:
646-786-5044

Attention:
David Wong, SVP – Corporate Controller

 

With a
copy (for informational purposes only) to:

Cahill
Gambino, LLP

405 Lexington
Avenue, 7th FL

New York,
New York 10174

Fax No.:
(518) 584-1962

Attention:
David G. Nichols, Jr.

DAHER
BONDS INVESTMENT COMPANY

c/o Delta
Trading

P.O. Box
241

Ferzol
Main Road

Bekaa
Valley, Lebanon

    	Schedule B - Page 2

    	 

    

 

With a
copy (for informational purposes only) to:

Golenbock
Eiseman Assor Bell & Peskoe LLP

437 Madison
Avenue

New York,
New York 10022

Fax No.:
(212) 907-7385

Attention:
Andrew Peskoe, Esq.

 

MIDA HOLDINGS

c/o Delta
Trading

P.O. Box
241

Ferzol
Main Road

Bekaa
Valley, Lebanon

 

With a
copy (for informational purposes only) to:

Golenbock
Eiseman Assor Bell & Peskoe LLP

437 Madison
Avenue

New York,
New York 10022

Fax No.:
(212) 907-7385

Attention:
Andrew Peskoe, Esq.

 

XOL HOLDING
S.A.L.

Attn:
President

Dedeian
Building 1st Floor

Naher
Al Mout Street, Metn

Lebanon

Tel +961-3-777256

 

with copies
to (which shall not constitute notice):

Tarter
Krinsky & Drogin LLP

1350 Broadway,
11th Floor

New York,
NY 10018

Attention: 
James G. Smith, Esq.

Tel: (212)
216-8000

Fax: (212)
216-8001

jsmith@tarterkrinsky.com

 

HENDRIK
IWEMA

Drielander
8

8253  B2
 Dronten

Holland

 

TRIMARC
CAPITAL FUND, L.P.

400 Madison
Avenue, Suite 9D

New York,
NY 10017

Fax: (646)
607-9008

Attention:
Michael Trica

    	Schedule B - Page 1

    	 

    

 

Schedule
C

 

Stockholders
in Transactions

 

BONDS
MX, LLC

 

GFINET
INC.

OAK INVESTMENT
PARTNERS XII, LIMITED PARTNERSHIP

 

ROBERT
JONES

 

UBS
Americas Inc.

 

PLOUGH
PENNY PARTNERS, L.P.

 

RICHARD
COONS IRA

 

JEFFERIES
& COMPANY, INC.

 

daher
bonds investment company

 

XOL
HOLDING S.A.L.

 

HENDRIK
IWEMA

 

trimarc
capital fund, l.p.

 

 

8%
Series E Designee Holders

 

 

GFINET
INC.

 

OAK INVESTMENT
PARTNERS XII, LIMITED PARTNERSHIP

 

DAHER
BONDS INVESTMENT COMPANY

 

 

 

 

 

 Schedule
C

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}]]